Funding Organization

National Institute of Allergy and Infectious Diseases

1000 opportunities

About

No description available for this funder.

Grants (1000)

Mechanisms of HBx Recognition and Epigenetic Regulation of HBV cccDNA

open
Mar 29, 2029$50,114 - $50,114

Defining molecular determinants of resident memory T cell differentiation and persistence

open
Mar 31, 2030$36,673 - $36,673

Implementing novel CRISPR screening models to inform HIV cure strategies by characterizing primary human CD4 T cell resistance to CD8 cytotoxicity

open
Mar 31, 2029$50,114 - $50,114

Nonpeptidergic neurons suppress cutaneous inflammation via glutamate release

open
Mar 31, 2030$55,114 - $55,114

Investigating the Role of S. aureus Citrate Metabolism in Prosthetic Joint Infection

open
Mar 31, 2028$41,509 - $41,509

Investigating the cellular and molecular mechanisms of periventricular inflammation in neuroinflammatory CNS

open
Mar 31, 2029$35,448 - $35,448

Exploring the Impact of Paternal Immune Activation on Offspring Immunity to Viral Infection

open
Mar 31, 2028$50,114 - $50,114

Understanding the mechanism of action of repurposed antihypertensive drugs against Borrelia burgdorferi

open
Mar 31, 2029$46,302 - $46,302

Exploring the targeting and function of mitochondrial gasdermin D in macrophage-driven hyperinflammation

open
Mar 31, 2028$50,114 - $50,114

A deep mutational scan of the HIV-1 capsid core.

open
Mar 31, 2030$55,114 - $55,114

Exacerbation of Coxsackievirus B3-Induced Pancreatitis by NOD2 Autoregulation Across the Gut-Pancreas Axis

open
Mar 31, 2029$76,300 - $76,300

Investigating Relationships of the Upper Airway Microbiota with SARS-CoV-2 Susceptibility and Coronavirus Disease 2019 Disease Presentation

open
Mar 31, 2028$34,934 - $34,934

Elucidating the molecular mechanisms underlying defensosome biogenesis and release

open
Mar 31, 2029$50,114 - $50,114

The Role of Type I Interferon in Murine Roseolovirus Induced Autoimmune Gastritis

open
Jan 31, 2029$36,673 - $36,673

Regulation of spore germination by an intrinsically disordered protein

open
Mar 31, 2029$46,302 - $46,302

Role of Arid1a in NK cell development and antiviral immunity

open
Apr 2, 2029$46,564 - $46,564

Novel Gene Variants of ZFYVE21 and Dysregulated Innate Immunity

open
Mar 31, 2031$778,828 - $778,828

Investigating the impact of type I IFN signaling on regulatory T cell function during mucosal HSV-2 infection

open
Apr 7, 2028$49,343 - $49,343

Dissecting the protective and pathogenic functions of Tbet+CD11c+ B cells in differing inflammatory environments

open
Apr 6, 2029$50,114 - $50,114

Deciphering Residual Malaria Mechanisms in the Peruvian Amazon to Inform Novel and Effective Control Strategies

open
Mar 31, 2031$580,306 - $580,306

AAV-delivered meganucleases for durable control of genital HSV disease

open
Mar 31, 2028$232,558 - $232,558

Consequences of mast cell activation and complement dysregulation in eosinophilic esophagitis

open
Mar 31, 2031$207,995 - $207,995

RNA Ribosylation's Role in Viral RNA Biology and Innate Immunity

open
Mar 31, 2028$229,714 - $229,714

Immunogenicity and Safety of High-Dose vs. Standard-Dose Influenza Vaccines Administered Over Consecutive Seasons to Lung Transplant Recipients

open
Mar 31, 2031$887,964 - $887,964

Examining the mechanisms underlying Libby Amphibole associated autoimmunity

open
Mar 31, 2030$138,803 - $138,803

Impact of Host Genetic Variants on Regulating Chikungunya Virus-Induced Disease

open
Mar 31, 2028$229,360 - $229,360

Transcriptional Mechanisms that Catalyze Dysregulated Type 17 Mucosal Inflammation via Innate Lymphoid Cells

open
Mar 31, 2031$201,744 - $201,744

Impact of Mechanical Circulatory Support and Microbiome Change on Outcomes in Heart Transplant Recipients

open
Mar 31, 2031$196,020 - $196,020

Human Intestinal Organoids as a Model for Acute GI-ARS

open
Mar 31, 2031$560,175 - $560,175

Mapping the determinants of bedaquiline resistance in Mycobacterium tuberculosis

open
Mar 31, 2028$403,756 - $403,756

Ultra-long-acting in-situ forming implant (ISFI) as a subcutaneous injection for prevention of HIV and unplanned pregnancy

open
Mar 31, 2028$1,106,984 - $1,106,984

Novel Pediatric TB Diagnostics using Host and Microbial Biomarkers

open
Mar 31, 2028$210,302 - $210,302

Epigenetic regulation of neo-sex chromosomes in filarial parasites

open
Mar 31, 2028$440,211 - $440,211

Understanding Multidrug-Resistant Pathogen Infections and their Treatment with Antibiotics and Bacteriophages

open
Mar 31, 2028$161,244 - $161,244

The role of ZBP1 in controlling HSV-1 pathogenesis

open
Mar 31, 2031$660,723 - $660,723

Determinants of viral assembly and infectivity within the Ebola virus VP24 protein

open
Mar 31, 2031$843,182 - $843,182

Development of molecular tools and mouse models to study neglected Sindbis virus genotypes and their epidemic potential

open
Mar 31, 2028$88,250 - $88,250

Mentoring patient-oriented research on point-of-care diagnostics for infectious diseases

open
Mar 31, 2031$209,758 - $209,758

Molecular Mechanisms of Aire in Transcriptional Regulation

open
Mar 31, 2028$267,000 - $267,000

Adaptable and hemodynamic Gut-On-VascularNet models to mitigate radiation injury

open
Mar 31, 2031$608,000 - $608,000

The Use of the Pig-to-Human Decedent Model to Optimize Future Results in Clinical Xenotransplantation Trials

open
Mar 31, 2031$2,064,597 - $2,064,597

Characterizing a Novel Toxin in Interbacterial Competition Among B. fragilis

open
May 31, 2029$36,673 - $36,673

Acquisition of essential nutrient lysine by Staphylococcus aureus during invasive infection

open
Mar 31, 2028$50,114 - $50,114

Mechanisms of Nuclear Egress in Gamma-herpesviruses

open
Mar 31, 2028$46,302 - $46,302

Leveraging Large Language Models for the Design of Monoclonal Antibodies Against Malaria

open
Mar 31, 2028$282,757 - $282,757

Identifying the functional impact of ZNF688 autoantibodies in oral lupus lesions

open
Mar 31, 2027$160,100 - $160,100

Immune regulatory role of reactive oxygen species (ROS) in sepsis

open
Mar 31, 2031$760,700 - $760,700

Modeling Dirty Timestamp Mice to Assess the Impact of Perinatal Exposure to Diverse Pathogenic Microbes on the Functional Programming of Group 1 ILCs

open
Mar 31, 2028$411,078 - $411,078

Modeling the Vaginal Microbiome: Predicting BV Recurrence and Identifying Preventative Targets

open
Mar 31, 2028$427,625 - $427,625

Interleukin 33 signaling beneficially regulates pathologic glia in multiple sclerosis

open
Mar 31, 2031$157,788 - $157,788

Unique Antibody Structural Variegation Mechanisms

open
Mar 31, 2031$976,318 - $976,318

Protective mRNA Vaccines Against Tuberculosis

open
Mar 31, 2031$717,003 - $717,003

Interplay of heterosexual male-female partner microbiomes, Chlamydia trachomatis and transmission

open
Mar 31, 2031$816,421 - $816,421

Reassessing West Nile virus action thresholds for improved disease control

open
Mar 31, 2028$436,157 - $436,157

Development of a Humanized IL33 Mouse

open
Mar 31, 2028$174,824 - $174,824

Inter-strain recombinants of human cytomegalovirus as an in vitro model of in vivo genetic diversity.

open
Mar 31, 2028$147,000 - $147,000

Enhancing Host Defense Against Bacterial Pneumonia in Lipodystrophy: Evaluating the Therapeutic Potential of Leptin and Tirzepatide

open
Mar 31, 2028$429,000 - $429,000

A Cluster Randomized Stepped-Wedge Effectiveness-Implementation Trial of a Patient Decision Aid to Increase Sexually Transmitted Infection Testing in the Emergency Department: The STIckER Trial

open
Mar 31, 2031$872,037 - $872,037

Serotype re-emergence and vaccine impact in the era of next-generation pneumococcal vaccines

open
Mar 31, 2031$792,513 - $792,513

Development and Support of the Pathway Tools Software

open
Mar 31, 2030$1,219,508 - $1,219,508

Defective HIV-1 proviral abundance and their immune effects in children and adolescents living with perinatal HIV-1

open
Mar 31, 2031$779,616 - $779,616

Microbial drivers of oral vaccine failure

open
Mar 31, 2028$242,250 - $242,250

Role and regulation of methylarginine effector TDRD3 in T cell immunity

open
Mar 31, 2031$794,183 - $794,183

Development of full thickness human skin model for investigating the mechanism(s) of radiation induced skin injuries and therapeutics development

open
Mar 31, 2031$556,457 - $556,457

Novel Long-Acting HBV Capsid Assembly Modulators

open
Mar 31, 2028$954,603 - $954,603

Understanding the mechanisms of maternal antibody interference with oral vaccination

open
Mar 31, 2031$653,742 - $653,742

Advancing iPSC-derived Thymic Epithelial Cells as Cell Therapy for T Cell Immune Reconstitution in Vulnerable Populations(original application ID AI190181-01)

open
Mar 31, 2031$809,250 - $809,250

Advancing Analytical Tools to Quantify and Mitigate the Risk for Transitioning from Episodic to Endemic Transmission for Emerging Infections

open
Mar 31, 2031$787,837 - $787,837

Unraveling the Biosynthesis of Aromatic Virulence Factors in Pseudomonas aeruginosa

open
Mar 31, 2029$470,978 - $470,978

Development of broadly protective Lassa vaccines using the Pichinde virus vector

open
Mar 31, 2028$192,500 - $192,500

Understanding carnitine reprogramming in sepsis

open
Mar 31, 2031$194,904 - $194,904

Discovery and Development of Novel Antimalarial Drugs

open
Mar 31, 2031$791,611 - $791,611

Mechanisms of respiratory viral infections in hospitalized children

open
Mar 31, 2031$598,906 - $598,906

Lipidomic discovery of physiological CD1 antigens and blockers for human T cells

open
Mar 31, 2031$893,459 - $893,459

Development of 3D Multi-cellular Cardiac Tissues for Modeling Delayed Radiation-induced Injury

open
Mar 31, 2031$538,838 - $538,838

A Sicangu-driven social network strategy for syphilis prevention

open
Mar 31, 2028$417,567 - $417,567

Cytosolic DNA sensing pathway regulation via non-canonical NF-kB signaling

open
Mar 31, 2031$372,997 - $372,997

Mechanisms of Macrophage Manipulation by pathogenic SFG Rickettsia: Role of Mitochondrial and Immune Pathways

open
Mar 31, 2027$440,949 - $440,949

Targeting Evasion Factors: Discovery of novel antibodies for durable suppression of HSV reactivation

open
Mar 31, 2028$215,758 - $215,758

A mouse model to analyze Foxp3+ TFH cells

open
Mar 31, 2028$158,500 - $158,500

Omics/Clinical Core

open
Mar 31, 2027$311,474 - $311,474

Research Project 1: Epidemiology of malaria species and their natural history in human hosts

open
Mar 31, 2029$90,180 - $90,180

Correlates of protective immunity to HCV and rational vaccine design: Project 1

open
Mar 31, 2027$143,462 - $143,462

Novel Mechanisms of Genetic Errors of Immunity

open
Mar 31, 2030$2,483,910 - $2,483,910

Illuminating pediatric immunology through genetics

open
May 31, 2030$533,819 - $533,819

Statistical and Data Management Core

open
Jul 31, 2030$500,697 - $500,697

Pediatric Fungal Network's (PFN) STudy of Rare Invasive Fungal DisEases in Immunocompromised Pediatric Patients (STRIDE) Career Enhancement Core

open
Jul 31, 2030$138,924 - $138,924

Targeted therapy platform for eliciting memory-like NK cell responses

open
Mar 31, 2028$146,948 - $146,948

The impact of low-abundance commensals on gut colonization resistance

open
Mar 31, 2028$434,090 - $434,090

Development of new genetic tools for selective targeting plasma cells

open
Mar 31, 2028$161,500 - $161,500

Decoding the glycan forms of glycoRNA-L and glycoRNA-S from leukocytes

open
Mar 31, 2028$157,500 - $157,500

Development of a novel Guinea pig model that mimics human relapsing fever disease.

open
Mar 31, 2028$160,500 - $160,500

A Transposon-based Gene Drive to Combat Antimicrobial Resistance

open
Mar 31, 2031$171,046 - $171,046

The interplay of protein secretion and lipid virulence factors in host immune suppression by Mycobacterium tuberculosis

open
Mar 31, 2031$756,714 - $756,714

Molecular mechanisms by which S. aureus alpha-toxin impairs the antigen-specific T cell response

open
Mar 31, 2031$664,076 - $664,076

Effects of oxygen and bile acid processing on the small intestinal microbiome and colonization resistance

open
Mar 31, 2028$423,500 - $423,500

Inhibitors of the Reverse Transsulfuration Pathway as a New Treatment for Helicobacter pylori Infection

open
Mar 31, 2028$481,250 - $481,250

Mapping anti-filovirus humoral immune responses in broadly seroreactive individuals

open
Mar 31, 2028$279,000 - $279,000

Ex Vivo Delivery of Viral-Mediated Gene Therapy for the Amelioration of Post-Transplant Rejection

open
Mar 31, 2031$597,613 - $597,613

Mechanisms of cryptococcal IRIS

open
Mar 31, 2031$749,353 - $749,353

Identification and elimination of antigen-specific expanded clones

open
Mar 31, 2028$427,438 - $427,438

Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (allo-HCT) Recipients

open
Mar 31, 2031$919,820 - $919,820

Maternal vaccination to prevent Klebsiella pneumoniae gut colonization and neonatal sepsis

open
Mar 31, 2031$726,966 - $726,966

Early regulation of T follicular helper cell differentiation via stroma-derived Notch signals

open
Mar 31, 2028$50,114 - $50,114

Regulation of donor specific antibody production

open
Mar 31, 2031$690,359 - $690,359

Endogenous Retroviruses and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

open
Mar 31, 2031$388,229 - $388,229

Exploiting symbiosis to identify novel antifungals to combat emerging drug-resistant pathogens

open
Mar 31, 2028$411,078 - $411,078

Regulatory T Cells and Lymphatic Endothelial Cells: Regulatory Interactions for Migration and Suppression

open
Mar 31, 2031$559,800 - $559,800

Identification and Investigation of CD4+ T cell Clonotypes Comprising a Polyclonal Repertoire Against Aeroallergen in a Murine Model of Allergic Asthma

open
Mar 31, 2028$421,098 - $421,098

Determining the role of micronutrient deficiency in the immune response to oral rotavirus vaccine in a low-resource setting.

open
Mar 31, 2028$228,000 - $228,000

Time resolved structural analyses of β-lactam/β-lactam inhibitor binding to AmpC

open
Mar 31, 2031$799,572 - $799,572

The upper intestinal environment and mediators of human cholera severity

open
Mar 31, 2031$581,755 - $581,755

A Single Long-Acting Injection For HBV Treatment Using Novel Entecavir Prodrugs For PWLH

open
Mar 31, 2031$899,741 - $899,741

Vaccine Strategies for Preventing Pandemic Influenza Viruses

open
Mar 31, 2031$799,792 - $799,792

Immune homeostasis during Borrelia burgdorferi infection

open
Mar 31, 2031$700,997 - $700,997

Passive immunization to prevent vertical papillomavirus transmission in a preclinical mouse model

open
Mar 31, 2028$234,900 - $234,900

Caregiver Beliefs and Psychosocial Experiences Related to Emerging Treatment Options for Children with Food Allergy

open
Mar 31, 2028$182,000 - $182,000

Genetic and functional dissection of tissue-infiltrating and age-associated B cells in murine lupus

open
Mar 31, 2031$499,175 - $499,175

Decoding cellular networks governing respiratory mucosal IgA immunity

open
Mar 31, 2031$773,388 - $773,388

Human Airway Macrophage Immunity in Tuberculosis: Defining Early Determinants of Infection

open
Mar 31, 2031$757,038 - $757,038

Speeding Immune Reconstitution after Thymus Transplantation

open
Mar 31, 2028$444,125 - $444,125

Multiplex binding antibody assay for confirmatory HSV-1/2 serological diagnosis

open
Mar 31, 2028$270,591 - $270,591

Novel Genetic Approaches to Elucidate Critical Signaling Pathways in Leishmania donovani

open
Mar 31, 2028$429,000 - $429,000

AI-powered multimodal precision sensing system to track tick phenotypic responses in natural and simulated environments

open
Mar 31, 2028$415,584 - $415,584

Enhancing Influenza Vaccines through Genetic Surveillance: Can Better Antigenic Match Improve Population Health?

open
Mar 31, 2031$182,422 - $182,422

A multi-biologic, AAV-deliverable HIV-1 functional cure

open
Mar 31, 2031$889,519 - $889,519

Elucidating how environmental perturbations determine the duration of enteric viral infection

open
Mar 31, 2031$627,483 - $627,483

Identification of Host Factors that Mediate the Nuclear Retention of Unspliced and Partially Spliced HIV-1 Transcripts

open
Mar 31, 2028$427,626 - $427,626

Investigating the developmental and transcriptional bases for distinct functions of IL-10+ and IL-10− Treg cells

open
Mar 31, 2028$167,951 - $167,951

Characterizing autoreactive B cells and their roles in the pathogenesis of SLE using immune organoids

open
Mar 31, 2028$127,926 - $127,926

Long-noncoding RNAafu-182- A novel regulator of fungal triazole tolerance

open
Mar 31, 2031$418,378 - $418,378

Pathogenesis of S. aureus thymidine-dependent small-colony variants

open
Mar 31, 2028$533,850 - $533,850

Assessing the tolerability and versatility of the new Spytag003/Spycatcher003 as a novel bio-conjugation system for displaying protein antigens on the surface of bacteriophage VLPs

open
Mar 31, 2029$587,528 - $587,528

Defining the T cell state that sustains chronic allergic disease

open
Mar 31, 2031$193,600 - $193,600

Structure and ligand binding of receptor adenylate cyclase from Trypanosoma brucei

open
Mar 31, 2028$157,500 - $157,500

Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses

open
Mar 31, 2028$456,500 - $456,500

Identification of bacterial isolates and communities that influence male life history traits and mating success among genetically diverse Ae. aegypti mosquitoes

open
Mar 31, 2031$525,789 - $525,789

Transforming ANA Testing: Leveraging Epidemiology and AI to Detect Autoimmune Disease

open
Mar 31, 2031$800,097 - $800,097

Dissecting the Contribution of Neutrophils to Diabetes/Tuberculosis Comorbidity

open
Mar 31, 2028$259,125 - $259,125

Antibody signatures of HIV treatment effectiveness: toward low-cost rapid tests for treatment monitoring

open
Mar 31, 2031$841,719 - $841,719

Novel structural and functional insights into T cell metabolism in healthy and disease states

open
Mar 31, 2027$50,114 - $50,114

Post-initiation control of Pseudomonas aeruginosa exopolysaccharide biosynthesis operons

open
Mar 31, 2028$439,094 - $439,094

Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators

open
Mar 31, 2028$249,000 - $249,000

Coreceptor therapy-induced de-differentiation of autoreactive Tfh

open
Mar 31, 2028$427,625 - $427,625

Genetic and Immunological Investigation of ABCF1 in Celiac Disease and Autoimmunity

open
Mar 31, 2031$661,009 - $661,009

Defining Particle-Associated Rotavirus NSP4

open
Mar 31, 2028$240,000 - $240,000

Leveraging phenazine cycling to understand maintenance metabolism in Pseudomonas aeruginosa

open
Mar 31, 2031$711,488 - $711,488

Developing a Molecular Taxonomy for Immune-Mediated Diseases

open
Mar 31, 2031$641,889 - $641,889

Light-Assisted Drying: A Novel Method for Stabilizing Inactivated Poliovirus Vaccine in a Sugar Glass for Room-Temperature Storage

open
Mar 31, 2028$142,910 - $142,910

Comparison of adaptive immunity between different Salmonella serovers

open
Mar 31, 2028$412,206 - $412,206

Defining the Molecular Epidemiology of Leishmaniasis in Texas Through a One Health Approach.

open
Mar 31, 2028$461,187 - $461,187

House dust-mite allergen-specific T cell subsets in allergy and asthma

open
Mar 31, 2031$536,810 - $536,810

Multi-omics Analysis of Bacteria-Host Interactions in Brugia malayi, a Medically Important Nematode with a Wolbachia Endosymbiont

open
Mar 31, 2031$678,218 - $678,218

N Protein Nexus: Rewiring Host Translation Machinery for SARS-CoV-2's Early Replicative Advantage

open
Mar 31, 2028$213,048 - $213,048

Ecology of Plasmodium malariae transmission in Cameroon

open
Mar 31, 2028$88,560 - $88,560

Role of GLI2 in antibody production

open
Mar 31, 2029$568,367 - $568,367

Systematic exploitation of synergy to improve tuberculosis therapy.

open
Mar 31, 2031$698,387 - $698,387

Characterization of basophils in urinary tract infections

open
Mar 31, 2028$458,364 - $458,364

Origin and function of non-canonical CX3CR1+ neutrophils

open
Mar 31, 2031$735,631 - $735,631

Intracellular bacteria hijack ER-Golgi transport to facilitate infection

open
Mar 31, 2031$670,881 - $670,881

Virulence mechanisms regulating Candida-driven vaginal epithelial exfoliation

open
Mar 31, 2031$777,795 - $777,795

Complement convertase imaging techniques for optimization of complement therapeutic amelioration of antibody mediated rejection

open
Mar 31, 2030$3,267,712 - $3,267,712

Discovery and Optimization of Broadly Protective Merbecovirus Neutralizing Antibodies

open
Mar 31, 2031$829,735 - $829,735

Passive immunotherapy for measles infection

open
Mar 31, 2031$855,113 - $855,113

Mechanisms of food-specific antibody induction in the gut

open
Mar 31, 2031$493,889 - $493,889

DNA ADP-ribosylation in the bacterial-phage arms race

open
Mar 31, 2031$638,220 - $638,220

Elucidating the role of genome organization in cDC1 development

open
Mar 31, 2028$162,000 - $162,000

Impact of environmental stress-induced adaptive immune responses on tissue physiology and tumorigenesis.

open
Mar 31, 2028$162,000 - $162,000

Identifying signaling networks that contribute to Th17-mediated neuroinflammation

open
Mar 31, 2031$762,086 - $762,086

Complement-mediated clearance of extracellular mitochondria

open
Mar 31, 2028$485,375 - $485,375

Modulation of HIV immune control by HLA-E-VL9 and HLA-E-VL9 binding antibodies

open
Mar 31, 2028$106,164 - $106,164

Role of myeloid KLF2 in the neonatal innate immune response

open
Mar 31, 2031$165,240 - $165,240

Proximal regulation of innate immune signals in ischemia reperfusion injury

open
Mar 31, 2028$184,000 - $184,000

Delving into peptide specificity of NK inhibitory receptors

open
Mar 31, 2028$423,500 - $423,500

Regulation of Filovirus mRNA translation

open
Mar 31, 2028$204,375 - $204,375

Antimicrobial Polymers for Treatment of Multidrug-Resistant Wound Biofilm Infections

open
Mar 31, 2030$2,641,186 - $2,641,186

HIV-1 antibodies in the presence of tuberculosis and other coinfections

open
Mar 31, 2031$872,596 - $872,596

Peptide-conjugated phosphodiamidate morpholino oligonucleotide (PPMO)-based henipavirus therapeutics

open
Mar 31, 2028$475,339 - $475,339

The role of organelle contact sites in macrophage antifungal responses

open
Mar 31, 2028$194,400 - $194,400

Aptamer tools for the study of HIV capsid structure, function, and interactions.

open
Mar 31, 2031$538,501 - $538,501

Cell polarity in the obligate intracellular pathogen Rickettsia parkeri

open
Mar 31, 2028$423,355 - $423,355

Rapid Cell-Based UTI Diagnosis and Antibiotic Selection Test

open
Mar 31, 2030$617,438 - $617,438

Deciphering the activation mechanisms and immune functions of GSDMC

open
Mar 31, 2030$2,469,932 - $2,469,932

A Microfluidic-Free Droplet Technology for Rapid and Quantitative Airborne Pathogen Monitoring

open
Mar 31, 2028$451,000 - $451,000

Generation of a non-cleavable allele of Pik3ip1/TrIP

open
Mar 31, 2028$135,586 - $135,586

Dissection of Shigella pathogenesis in vivo using a new oral infection mouse model

open
Mar 31, 2031$751,663 - $751,663

Development of a therapeutic antibody cocktail against New World Arenaviruses

open
Mar 31, 2031$923,708 - $923,708

A novel pentavalent circular RNA-based EBV vaccine

open
Mar 31, 2031$932,172 - $932,172

Establishing the etiology of chronic placental villitis of unknown etiology

open
Mar 31, 2031$689,081 - $689,081

Dissecting the intrinsic role of SLC4A2 in the development of liver inflammation in a mouse model of PBC

open
Mar 31, 2027$164,000 - $164,000

Dissecting the impact of gut evolution on Klebsiella pneumoniae pathogenesis.

open
Mar 31, 2028$435,875 - $435,875

Impact of regulatory dendritic cells in neonatal immune responses to Influenza infection

open
Mar 31, 2031$490,611 - $490,611

An Assay for Paenibacillus Detection in Low Resourced Settings

open
Mar 31, 2028$267,704 - $267,704

Anti-inflammatory effects of reverse transcriptase inhibitors during bacterial infection

open
Mar 31, 2028$158,800 - $158,800

Human upper airway immune memory kinetics and durability against respiratory pathogens

open
Mar 31, 2031$159,300 - $159,300

Modeling SARS-CoV-2 variant emergence from immunocompromised hosts

open
Mar 31, 2031$161,946 - $161,946

Increasing Breadth of Immune Response by Single-Dose Influenza Vaccines

open
Mar 31, 2031$721,365 - $721,365

Investigating the immunomodulatory role of the Nonclassical MHC Molecule HLA-F in Human Pregnancy

open
Mar 31, 2031$818,457 - $818,457

Statistical Models for Estimating Spatial and Sub-population HIV Epidemics

open
Mar 31, 2031$842,720 - $842,720

Neutralizing antibody pressure on the evolution of SARS-CoV-2 variants."

open
Mar 31, 2031$194,160 - $194,160

Exploration of the bacterial polyadenylase PAP I as an antimicrobial drug target

open
Mar 31, 2028$430,375 - $430,375

Surveillance of antibiotic resistance in natural commensal Neisseria populations: Reservoirs of resistance for important human pathogens

open
Mar 31, 2029$561,410 - $561,410

Mentoring in Anti-Infective Clinical Pharmacology and Pharmacometrics

open
Mar 31, 2031$203,556 - $203,556

Species-specific Yeast RNAi Pesticides for Sand Fly Control

open
Mar 31, 2028$464,176 - $464,176

Mechanisms underlying Phage-Antibiotic Synergy and Resistance in Daptomycin-Resistant Enterococcus faecium

open
Mar 31, 2028$455,719 - $455,719

Hijacking the neonatal Fc receptor: the novel biology of arterivirus entry, transmission, and persistence

open
Mar 31, 2031$615,446 - $615,446

Integrated Program for Cutaneous Immune-Stromal Interactions in SLE (IPCISS)

open
May 31, 2030$1,540,008 - $1,540,008

Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal

open
Apr 30, 2029$590,328 - $590,328

Temporal Regulation of mRNA Biogenesis in Immune Responses

open
Feb 9, 2027$34,370 - $34,370

Synergistic Nanobodies for Pandemic Preparedness

open
Jan 31, 2030$876,480 - $876,480

Development and application of pediatric-specific blood transcriptional modules across diverse geographical settings through public data mining

open
Jan 31, 2027$286,791 - $286,791

Elucidating influenza-induced protection of malaria-associated respiratory distress syndrome in mice

open
Mar 31, 2027$192,500 - $192,500

Nanobody-mediated proteolysis of Aspergillus fumigatus transcription factors in vitro and in vivo

open
Jan 31, 2027$197,420 - $197,420

Characterization of TOX isoform-specific roles in T cell and ILC development

open
Jan 31, 2027$250,500 - $250,500

In vivo functional characterization of a novel protein encoded by a lncRNA

open
Jan 31, 2027$74,346 - $74,346

Characterization of a novel chimeric autoantigen receptor (CAAR) treatment for Graves' disease

open
Feb 23, 2028$440,333 - $440,333

Single-cell transcriptional atlas of Giardia encystation

open
Jan 31, 2027$218,767 - $218,767

Immunobiology of a novel human DAMP receptor, its murine homolog, & their ligand

open
Jan 31, 2030$578,093 - $578,093

Characterization of a novel post-transcriptional regulator in P. aeruginosa

open
Jan 31, 2030$868,776 - $868,776

An integrated multiplexed diagnostic assay targeting fusion lipoproteins and cardiolipin for detection of treponemal and nontreponemal antibodies in syphilis patients

open
Jan 31, 2029$692,013 - $692,013

Mosquito extracellular vesicles in malaria parasite killing and immune priming

open
Jan 31, 2030$648,924 - $648,924

Evolved cefiderocol resistance and cross protection

open
Jan 31, 2030$794,849 - $794,849

Dynamic FOXP3 Expression in the Development of Regulatory T cells from Induced Pluripotent Stem Cells

open
Jan 31, 2030$196,992 - $196,992

Development of broadly neutralizing human monoclonal antibodies against henipaviruses

open
Jan 31, 2030$830,098 - $830,098

[18F]fluoromannitol: A novel imaging agent to delineate osteomyelitis in sickle cell disease

open
Jan 31, 2029$894,735 - $894,735

Mechanisms of STAT1 and STAT3 canonical and persistent activation in physiology and disease

open
Feb 28, 2030$639,485 - $639,485

Molecular details of the IgE antibody response to galactose-alpha-1,3-galactose in alpha-gal syndrome

open
Feb 28, 2030$753,304 - $753,304

mRNA-Based Vaccines Against Tick Borne Thogotoviruses

open
Feb 28, 2027$207,262 - $207,262

Host-Microbe Interactions and SARS-CoV-2 Susceptibility and Symptoms in aNovel Human Challenge Model

open
Jun 30, 2026$95,750 - $95,750

Development of an ETEC multivalent subunit vaccine using outer membrane vesicles

open
Feb 28, 2027$229,500 - $229,500

Active and passive humoral immunity to enteric adenovirus infection in Bangladeshi children

open
Feb 28, 2030$192,260 - $192,260

Host heterogeneity affects susceptibility of Babesia microti infection using vector-mediated transmission

open
Feb 28, 2027$250,573 - $250,573

Understanding the mechanism of tropism specific immune restriction in HIV infection

open
Feb 28, 2030$197,366 - $197,366

Hypoxia morphology of Aspergillus fumigatus impacts diagnostics

open
Feb 28, 2027$50,114 - $50,114

A single biosensors for the simultaneous molecular detection of HIV and Hepatitis B and C viruses at resource-limited settings

open
Feb 29, 2028$537,619 - $537,619

Membrane Protein Complexes in the M. Tuberculosis Divisome: Structures and Interactions

open
Feb 28, 2030$668,549 - $668,549

Care, Review, Assessment and Feedback Tool In Acute Respiratory infections (CRAFT-IAR)

open
Feb 28, 2030$873,716 - $873,716

Mechanism of parainfluenza virus genome replication

open
Feb 28, 2030$734,184 - $734,184

The Establishment of Lung Resident Self-Antigen-Specific CD4+ Tregs Following Acute Tissue injury

open
Feb 28, 2030$194,740 - $194,740

Streptococcus pneumoniae HtrA and its target interactions

open
Feb 28, 2027$234,000 - $234,000

The role of PPARd-controlled CIITA/MHCII expression in Treg's function in tumor immunity

open
Feb 28, 2027$237,500 - $237,500

Revealing the Mechanisms of Cleaved and Intact GSDMD Pore Formation and Membrane Rupture

open
Feb 29, 2028$38,123 - $38,123

Role of PKC Epsilon in Atheroprotection

open
Feb 28, 2027$205,000 - $205,000

Biophysical and genetic approaches to uncover ventral disc contractile attachment mechanisms in Giardia

open
Feb 28, 2030$718,086 - $718,086

Optimization of UltraPCR for detection of and assessment of treatment outcomes in Trypanosoma cruzi infection

open
Feb 28, 2030$504,703 - $504,703

Characterization of innate immune signaling pathways in the tick Ixodes scapularis

open
Feb 28, 2030$831,622 - $831,622

Determinants of reservoir contraction and expansion in vivo, ex vivo, and in vitro

open
Feb 28, 2030$648,378 - $648,378

Functions of the largest HSV-1 virion protein, pUL36

open
Feb 28, 2027$75,175 - $75,175

Reproductive and Child Health StaRR Program

open
Feb 28, 2030$402,731 - $402,731

Structural studies of the OrfX-type progenitor toxin complex of botulinum neurotoxin

open
Feb 28, 2030$616,816 - $616,816

Mechanisms and Consequences of c-di-GMP Control of Motility and Biofilm Formation

open
Feb 28, 2030$774,575 - $774,575

Defining the larval repertoire of Aedes aegypti somatosensory neurons

open
Feb 28, 2027$75,418 - $75,418

Handheld and population-based sequencing for rapid detection of new and repurposed drug resistance in M. tuberculosis

open
Feb 28, 2027$290,717 - $290,717

Mechanisms of Resistance and Clinical Outcomes of non-Carbapenemase Producing Carbapenem-Resistant Klebsiella pneumoniae Infections

open
Feb 28, 2027$259,461 - $259,461

COVID Global Mix - Global Mix / Investigation of COVID-19 Disease Parameters for Transmission Models in Low-Resource Settings

open
Feb 28, 2027$48,219 - $48,219

Dissecting innate immune control of intestinal and systemic Yersinia infection

open
Feb 28, 2030$1,024,897 - $1,024,897

Metabolic and epigenetic regulation of skin Tregs

open
Feb 28, 2030$597,542 - $597,542

Targeting monocyte allorecognition to achieve allograft acceptance

open
Feb 28, 2030$612,975 - $612,975

Development of Oral Immunotherapy against Clostridioides difficile Transmission

open
Feb 28, 2030$719,022 - $719,022

The role of caspase-3 mediated cleavage of VPS4A in restricting HSV-1

open
Jun 30, 2029$40,023 - $40,023

Naive CD8 T cell functional heterogeneity

open
Feb 28, 2030$658,849 - $658,849

Altered protein structures and neoepitopes in lupus neutrophils from dysregulated splicing of messenger RNA

open
Feb 28, 2027$256,808 - $256,808

Statistical methods for TCR-sequencing experiments

open
Feb 28, 2027$219,792 - $219,792

Regulation of the HA stem nanoparticle vaccine response by antigen duration

open
Feb 28, 2027$228,195 - $228,195

Therapeutic targeting the host hypoxia-response pathway to treat Mucormycosis

open
Feb 28, 2030$750,815 - $750,815

Defining successful intrahepatic CD4+ T cell responses against the hepatitis C virus

open
Feb 28, 2030$489,389 - $489,389

Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development

open
Mar 29, 2032$2,523,410 - $2,523,410

Efficient and Long-lived Brain Delivery of Neutralizing Antibodies Against Eastern Equine Encephalitis Virus for Post-exposure Therapy

open
Mar 31, 2027$240,300 - $240,300

Building tools to study commensal-specific CD8+ T cells in the small intestine

open
Mar 31, 2027$86,650 - $86,650

Uncovering the proviral role of B cell-intrinsic STAT1 expression during chronic gammaherpesvirus infection

open
Mar 31, 2028$49,538 - $49,538

Epithelial Immune Cell Interactions in Persistent T2 Inflammation

open
Mar 31, 2028$247,508 - $247,508

Virologic and immunologic impacts of active viral persistence in lung AMs of HIV-1-infected, cART-suppressed individuals

open
Mar 31, 2029$152,468 - $152,468

Co-benefits of co-delivery of long-acting antiretrovirals and contraceptives

open
Mar 31, 2027$329,173 - $329,173

Scaling function-first antibody discovery leveraging memory B cells

open
Mar 31, 2027$1,000,000 - $1,000,000

Investigating VICE domain functions tied to altered ribosome localization and translational flux during HSV-1 infection

open
Mar 31, 2027$34,114 - $34,114

Enhanced Antifungal Therapy to Improve Survival in Early Disseminated Cryptococcal Infection

open
Mar 31, 2028$274,913 - $274,913

A multidisciplinary approach to study ecotypes driving transmission and pathogenesis of Visceral Leishmaniasis (VL) and Post kala-azar dermal leishmaniasis (PKDL) in Eastern Africa

open
Mar 31, 2027$60,763 - $60,763

Identifying vulnerabilities in the long-lived HIV reservoir to accelerate its decay

open
Mar 31, 2028$32,698 - $32,698

Revealing the Structural Determinants of TCR Cross-Recognition via Extended Positional Scanning

open
Mar 31, 2027$78,220 - $78,220

Project 1: Human and Non-human Primate Influenza B-cell Repertoires

open
Mar 31, 2028$710,000 - $710,000

Molecular analysis of mother-to-child transmission of hepatitis B virus

open
Mar 31, 2030$621,698 - $621,698

Tropical Medicine Research Center for Talaromycosis in Vietnam

open
Mar 31, 2027$235,391 - $235,391

Optical Sequencing to Link Quantitative Bacterial Phenotypes to Human Mutations

open
Mar 31, 2027$199,506 - $199,506

Host Response to Hepatitis Delta Virus Infection

open
Mar 31, 2027$249,000 - $249,000

Developmental acquisition of memory-phenotype CD8+ T cell function in infection and cancer

open
Mar 31, 2029$55,114 - $55,114

Core-001

open
Mar 31, 2029$24,712 - $24,712

The effects of immunosuppression on SARS-CoV-2 persistence, virus genetic diversity and clinical outcomes of COVID-19

open
May 31, 2026$169,500 - $169,500

ICEMR Data Management Core

open
Mar 31, 2029$27,864 - $27,864

Alphavirus Pathogenesis and Immunity

open
Mar 31, 2030$782,871 - $782,871

Project-002

open
Mar 31, 2029$42,210 - $42,210

Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region

open
Mar 31, 2029$191,687 - $191,687

COVID Transmission and Morbidity in Malawi (COVID-TMM)

open
Mar 31, 2027$81,489 - $81,489

Identification of post-translationally modified antigens using genetic code expansion

open
Mar 31, 2027$223,451 - $223,451

Influence of hypoxia on the antiviral functions of human intestinal epithelial cells

open
Mar 31, 2030$646,188 - $646,188

Continuous in vitro culture and genetics of Plasmodium vivax in a bespoke blood cell bioreactor

open
Mar 31, 2028$406,450 - $406,450

Using Targeted, Controlled High Frequency Energy for Treatment of Onychomycosis

open
Mar 31, 2028$1,000,000 - $1,000,000

KSHV Infection And Persistence

open
Mar 31, 2030$857,354 - $857,354

Rapid Antibiotic Susceptibility Testing via Selective Lysis and Nanogap Trapping

open
Mar 31, 2030$490,093 - $490,093

Mechanisms of central nervous system invasion by the Lyme disease spirochete, Borrelia burgdorferi

open
Mar 31, 2027$192,500 - $192,500

Trispecific Killer Cell Engager for the Treatment of Systemic Lupus Erythematosus

open
Mar 31, 2027$235,500 - $235,500

Structural, functional, and microbiological exploration toward synergistic dual aminoglycoside combinations

open
Mar 31, 2027$237,518 - $237,518

Examining the influence of chromosome copy number on Pseudomonas aeruginosa persisters to fluoroquinolones

open
Mar 31, 2027$205,000 - $205,000

Interrogation of SidB-dependent septation for echinocandin potentiation in invasive aspergillosis treatment

open
Apr 14, 2027$40,960 - $40,960

The interplay of maternal antibody and newborn vaccine responses

open
Mar 31, 2030$793,102 - $793,102

Apolipoprotein E governs lymph node stromal cell function and lipid metabolism during autoimmunity

open
Mar 31, 2030$189,540 - $189,540

How to build a rib cage for a cell: the patterning, growth, and maturation of the cortical microtubules in Toxoplasma

open
Mar 31, 2030$563,513 - $563,513

SMART Use of Biologics in Chronic Rhinosinusitis with Nasal Polyposis

open
Mar 31, 2030$1,498,642 - $1,498,642

Toward field-ready paratransgenesis for malaria: bacterial strain optimization and microbiota interactions

open
Mar 31, 2030$606,815 - $606,815

Administrative Core - Drivers of influenza A virus transmission in humans

open
Mar 31, 2030$414,941 - $414,941

Assessing the Mycobacterium tuberculosis carriage state

open
Mar 31, 2027$187,998 - $187,998

Impact of Vpr-induced epigenetic remodeling on HIV persistence

open
Mar 31, 2030$610,527 - $610,527

Integrin-mediated regulation of type-1 dendritic cell positioning and function in lymph nodes

open
Mar 31, 2027$220,625 - $220,625

Evaluating Treatment Efficacy in Canine Visceral Leishmaniasis: The Role of Individual Factors and Co-Infections in Disease Control and Therapeutic Response.

open
Mar 31, 2027$77,000 - $77,000

The role of Alternaria fungal sensitization in asthma pathogenesis

open
Apr 30, 2026$175,000 - $175,000

Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention

open
Mar 31, 2028$180,640 - $180,640

Oral BCG: Optimizing mucosal vaccination against tuberculosis

open
Mar 31, 2030$1,162,224 - $1,162,224

Molecular investigations of HIV-1 maturation pathways and inhibitor actions in situ

open
Mar 31, 2030$859,992 - $859,992

Conserved NO-Binding Cytochromes in Burkholderia pseudomallei and Other Pathogens

open
Mar 31, 2027$216,165 - $216,165

Developing vaccines against the intracellular and extracellular Lifestages of the Cryptosporidium parasite

open
Mar 31, 2027$201,875 - $201,875

IL17 Signaling in Monogenic Type 1 Diabetes

open
Mar 31, 2027$164,000 - $164,000

Development of YK-4-250, a radiation mitigator of GI-ARS

open
Mar 31, 2030$552,787 - $552,787

Defining the role of the Brucella TIR-NAD hydrolase activity in immunosuppression and pathogenesis

open
Mar 31, 2027$233,250 - $233,250

Decoding T cell clonotypes, biology and predictive biomarkers associated with immune checkpoint Myocarditis

open
Apr 30, 2030$858,186 - $858,186

Unraveling the molecular mechanisms of innate immune memory in humans

open
Apr 30, 2030$735,078 - $735,078

Novel roles of Fc gamma binding protein in colonic host-microbiota interactions

open
Apr 30, 2027$222,750 - $222,750

Defining the role of the RGS12 locus in macrophage function

open
Apr 30, 2028$42,885 - $42,885

APOBEC3-driven host mechanism promotes poxvirus diversification to overcome host immune restriction

open
Apr 30, 2027$221,105 - $221,105

PD-1/PD-L1 signaling at the interface between immune and stem cell crosstalk

open
Apr 30, 2027$384,250 - $384,250

Microglial immunity in Toxoplasmic encephalitis

open
Apr 30, 2027$227,018 - $227,018

Identifying metabolic targets to reinvigorate T cell exhaustion

open
Apr 30, 2027$49,538 - $49,538

Protein display drug ANDI reduces asthmatic airway hyperreactivity

open
Apr 30, 2027$320,863 - $320,863

Next Generation ELQs for Treatment and Once-Monthly Protection Against Malaria

open
Apr 30, 2029$587,318 - $587,318

Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients

open
Apr 30, 2027$123,606 - $123,606

Development of novel multivalent mucosal vaccines for human noroviruses

open
Apr 30, 2030$798,173 - $798,173

Multidisciplinary studies on overcoming SARS-CoV-2 main protease drug resistance and on fitness costs

open
Feb 6, 2028$48,974 - $48,974

Uganda Schistosomiasis Multidisciplinary Research Centre (U-SMRC)

open
Apr 30, 2027$252,274 - $252,274

Defining a role and functional consequences of the disordered N-terminal domain from the Borna Disease Virus Phosphoprotein

open
Apr 30, 2028$36,046 - $36,046

Clinical Core

open
Apr 30, 2026$203,405 - $203,405

Investigating B cell central tolerance to a model commensal antigen

open
Apr 30, 2027$186,486 - $186,486

Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid

open
Apr 30, 2028$138,564 - $138,564

International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.

open
Apr 30, 2027$221,852 - $221,852

PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis

open
Apr 30, 2027$398,334 - $398,334

Learning from Remission and Relapse in SLE

open
Apr 30, 2029$90,908 - $90,908

LpxH Inhibitors as Novel Therapeutics Against Multidrug-resistant Enterobacterales

open
Apr 30, 2030$747,763 - $747,763

A Novel Electrochemical LFA for Diagnosing TB from a Single Drop of Blood

open
Apr 30, 2027$238,500 - $238,500

Assessing food-specific tolerogenic CD4+ T cells in protection from food allergy

open
Apr 30, 2027$49,538 - $49,538

Role of WDFY4 in Treg development

open
Apr 30, 2030$737,502 - $737,502

Randomized Control Trial of Nitazoxanide for the Treatment of Cryptosporidium Infection in Malnourished Children in Bangladesh

open
Apr 30, 2028$196,370 - $196,370

Human papillomavirus regulation of the Hippo signaling pathway

open
Apr 30, 2030$533,707 - $533,707

Development of Commensal-Specific T cell Studies

open
Apr 30, 2027$74,718 - $74,718

STRIVE: Short-Term Research in Immunology and Virology Experience

open
Apr 30, 2030$105,170 - $105,170

Harnessing the Host Response to Leptosporisis for Diagnosis and Prognosis

open
Apr 30, 2028$70,200 - $70,200

Central Africa International Epidemiology databases to Evaluate AIDS

open
Apr 30, 2026$227,788 - $227,788

Targeting TB transmission hotspots to find undiagnosed TB in South Africa: a genomic, geospatial and modeling study (TARGET- TB)

open
Apr 30, 2027$314,460 - $314,460

Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet)

open
Apr 30, 2027$220,447 - $220,447

Adaptive Immune Responses to Congenital and Postnatal Cytomegalovirus Infection

open
Apr 30, 2029$598,664 - $598,664

The Molecular Basis of Staphylococcus aureus SplB manipulation of the host

open
Apr 30, 2030$390,000 - $390,000

Metabolic determinants of Mtb virulence, vulnerability and variation

open
Apr 30, 2027$311,641 - $311,641

Virulence and Adaptation to the Host Environment of Pathogenic Leptospira

open
Apr 30, 2028$352,728 - $352,728

Interrogating the RIP kinase function of LRRK2 in chronic inflammation and susceptibility to infection.

open
Apr 30, 2027$162,000 - $162,000

Host-Pathogen Interaction in Leptospirosis

open
Apr 30, 2028$78,022 - $78,022

Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID)

open
Apr 30, 2028$28,397 - $28,397

Circularization of RNA to improve the durability of the vaccine immune response

open
Apr 30, 2030$798,400 - $798,400

EGF as an environmental cue of B. burgdorferi gene regulation

open
Apr 30, 2027$162,000 - $162,000

Investigating the chromatin remodeling functions of polyphosphate condensates in Pseudomonas aeruginosa

open
Apr 30, 2030$779,915 - $779,915

Increasing the protective capacity of antibodies by enhancing Fc-mediated responses

open
Apr 30, 2030$416,276 - $416,276

Role of ASIC1a activation in ECM associated brain injury and mortality

open
Apr 30, 2027$213,000 - $213,000

Immune signatures of CMV disease risk after orthotopic liver transplant

open
Apr 30, 2030$832,910 - $832,910

Autologous Non-viral CRISPR/Cas Homology-directed Repair for Artemis-deficient Severe Combined Immunodeficiency

open
Apr 30, 2030$200,016 - $200,016

Phosphatases in lupus

open
Apr 30, 2030$558,045 - $558,045

Determining Optimal Immunosuppression and Kidney Allocation Strategies for Mitigating Risks from Epstein-Barr Virus in Kidney Transplant Centers

open
Apr 30, 2030$644,770 - $644,770

Orchestration of the antibody response by PI3K-gamma

open
Apr 30, 2030$837,497 - $837,497

A global Infectious diseases framework to grow interdisciplinary research

open
Apr 30, 2030$146,170 - $146,170

Unraveling skin microbiota-immune interactions that drive early life commensal tolerance

open
Nov 6, 2026$47,767 - $47,767

Developing allogeneic iNKT cell adoptive therapy to improve outcomes for HSCT indications

open
Apr 30, 2027$306,500 - $306,500

Activation of type I interferon production in human immune cells by cell-to-cell transmission of HIV-1

open
Apr 30, 2028$479,925 - $479,925

Interpretable and Adaptable Graph Neural Networks: Modeling Metapopulation Dynamics of Vaccine-Preventable Childhood Infections

open
Apr 30, 2030$711,555 - $711,555

Transcriptional Regulation of human natural killer cell function

open
Apr 30, 2030$666,567 - $666,567

Accelerating Public Health Impact Through the University of Washington/NASTAD Research Alliance in Implementation Science to End HIV (RAISE) Regional Consultative Hub

open
Apr 30, 2030$623,243 - $623,243

Exploratory study of pesticide use and coccidioidomycosis

open
Apr 30, 2027$247,621 - $247,621

Structural interrogation of the HIV-1 virion and the mechanism of the capsid targeting compound Lenacapavir

open
Apr 30, 2026$653,693 - $653,693

Modulation of Pediatric Sepsis by Virus Persistence

open
Apr 30, 2030$721,728 - $721,728

Immune repertoire remodeling following B cell-targeted CAR T cells for induction of renal allograft tolerance in non-human primates

open
Apr 30, 2030$1,648,086 - $1,648,086

Engineering non-replicating self-recirculating phages as platform for gene therapy of the microbiome

open
Apr 30, 2027$233,250 - $233,250

A Novel Broad-Spectrum Nanoimmunotherapeutic Approach for Combating Multidrug Resistant Bacteria

open
Apr 30, 2030$392,634 - $392,634

Carbohydrate based multi-component vaccine against Bordetella pertussis

open
Apr 30, 2030$780,834 - $780,834

Influence of Maternal IgA on Neonatal iNKT Cell Development and Gluten Sensitive Enteropathy.

open
May 14, 2028$41,778 - $41,778

Functional Omics Core Laboratory

open
May 14, 2026$2,065,495 - $2,065,495

Control of Long-lived HIV Cellular Reservoirs in memory CD4+ T cells by Bach2

open
Apr 30, 2027$499,550 - $499,550

Identifying Mechanisms of Resistance to Pathogen-Specific Antibacterial Antisense Compounds and Strategies to Circumvent Them

open
Apr 30, 2027$254,478 - $254,478

Lead optimization of oral DHFR inhibitor for the treatment of multidrug-resistant N. gonorrhoeae infections.

open
Apr 30, 2028$1,000,000 - $1,000,000

Ubiquitin pathway modulators as novel antituberculosis drugs

open
Apr 30, 2027$302,421 - $302,421

Dysregulation of Gamma Secretase in Common Acquired Hidradenitis Suppurativa

open
May 14, 2028$54,538 - $54,538

Metabolic determinants of carbon dioxide tolerance in the pathogenic fungi, Cryptococcus neoformans

open
Apr 30, 2027$158,433 - $158,433

Esx5 secretome in TB and TB-HIV pathogenesis and immunity

open
Apr 30, 2030$820,246 - $820,246

Advanced development of multi-omics based assays to predict late radiation organinjuries - the DEARE-Watch project

open
Apr 30, 2030$570,849 - $570,849

Robust verification of genetic variant-associated candidate off-target sites

open
Apr 30, 2028$856,513 - $856,513

Validated Immunoassays to Accelerate Therapeutic Genome Editing INDs

open
Apr 30, 2028$715,222 - $715,222

Leveraging antibody-omics to prevent and detect TB in children affected by HIV

open
Apr 30, 2027$209,750 - $209,750

Development of immune evasive strategies for allogeneic cell replacement therapies

open
Apr 30, 2026$307,091 - $307,091

Clonal lineage tracing of HIV specific NK memory cells

open
Apr 30, 2027$220,000 - $220,000

Understanding formation and dynamics of the SIV reservoir.

open
Apr 30, 2027$824,331 - $824,331

Machine Learning to Modulate Influenza Immunity

open
Apr 30, 2030$1,195,056 - $1,195,056

Multimodal Nanoparticles for Severe Inflammation and Sepsis

open
Apr 30, 2030$684,206 - $684,206

Clinical Pharmacology Quality Assurance (CPQA)

open
May 29, 2026$1,836,411 - $1,836,411

Exploring innate immune responses to rhinovirus in allergic asthma

open
Apr 30, 2027$80,750 - $80,750

Identification and targeting of metabolic profiles in cytotoxic T-lymphocyte (CTL)-resistant, HIV-infected CD4+ T-cells

open
May 27, 2028$49,538 - $49,538

Rapid Stress Response in Bacterial Pathogens: the Role of Extant Porins in Antibiotic Tolerance

open
Apr 30, 2030$637,275 - $637,275

DEVELOPMENT OF MONOCLONAL ANTIBODIES TO CHEMOKINES IN THE FERRET MODEL OF RESPIRATORY DISEASE.

open
May 31, 2027$599,987 - $599,987

Enhancing the utility of deer mice as an infectious disease model

open
May 31, 2030$466,725 - $466,725

Understanding the role of ubiquitination-like processes in bacterial antiviral immunity

open
Oct 31, 2027$42,843 - $42,843

Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment

open
May 31, 2027$93,590 - $93,590

An integrated approach to understand and diagnose congenital Chagas disease

open
May 31, 2027$119,448 - $119,448

Home Fingerprick Blood-Based HIV Self-Test For Quantitative Monitoring Of Viral Rebound

open
Aug 31, 2026$554,633 - $554,633

Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru

open
May 31, 2027$668,530 - $668,530

Understanding HIV's impact on RR/MDR-TB development and transmission through genomics

open
May 31, 2026$20,698 - $20,698

Linking Mycobacterium Tuberculosis infection outcomes with transcriptional networks in genetically diverse mouse macrophages

open
May 31, 2028$35,130 - $35,130

Separating the molecular determinants that govern the evolution of Orthoflavivirus NS5-mediated IFN antagonism

open
May 31, 2028$49,538 - $49,538

A more durable and universal adjuvanted influenza vaccine through synthetic biology

open
May 31, 2027$599,526 - $599,526

ANTIBODY REAGENTS FOR IMMUNOLOGIC ANALYSIS OF UNDER-REPRESENTED MAMMALIAN MODELS

open
May 31, 2028$1,500,000 - $1,500,000

Sustained Release of Potent Antiviral Prodrugs for HIV Prevention

open
May 31, 2026$67,212 - $67,212

M. tuberculosis exosome detection for pediatric TB diagnosis

open
May 31, 2027$104,166 - $104,166

DON in Pediatric Cerebral Malaria: A Phase I / II Dose-Escalation Safety Study

open
May 31, 2027$548,344 - $548,344

Cellular Immunology Core Laboratory

open
May 31, 2026$2,573,880 - $2,573,880

Morphological and molecular identification of Hyalomma tick vectors of Crimean-Congo Hemorrhagic Fever virus

open
May 31, 2028$355,000 - $355,000

Clinical Impact of the Cefazolin Inoculum Effect

open
May 31, 2028$161,779 - $161,779

Genetics & Clinical Cohorts

open
May 31, 2026$155,060 - $155,060

Diagnostic Innovations for Pediatric Tuberculosis in Bolivia

open
May 31, 2028$120,406 - $120,406

Host and parasite factors influencing P. vivax RBC invasion and asexual development

open
May 31, 2027$154,170 - $154,170

Malaria associated pathogenesis of chronic kidney disease (MAP-CKD)

open
May 31, 2027$263,811 - $263,811

Lung Transplant Clinical Trial Network (LT-CTN)

open
May 31, 2028$297,730 - $297,730

Chromatin Biology of the African Trypanosome

open
May 31, 2027$1,057,830 - $1,057,830

Understanding the Molecular Rules of a Bacterial Multidrug Efflux Transporter

open
May 31, 2027$36,868 - $36,868

Biochemical Mechanism of HIV DNA Integration

open
May 31, 2030$819,601 - $819,601

Defining Mechanisms for Plasmacytoid Dendritic Cell-driven Mycobacterium tuberculosis Susceptibility

open
May 31, 2027$162,000 - $162,000

Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy

open
May 31, 2028$999,658 - $999,658

Host Pathogen Variation & TB Pathogenesis

open
May 31, 2026$210,900 - $210,900

Effectively Linking Molecular Informatics and Network Analytics to Reduce Malaria (ELIMINAR-Malaria)

open
May 31, 2028$22,000 - $22,000

East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium

open
May 31, 2026$195,343 - $195,343

Novel strategies for treatment of Mycobacterium abscessus pulmonary disease

open
May 31, 2026$240,878 - $240,878

Vaccine- and infection-derived correlates of protection for cholera

open
May 31, 2029$236,187 - $236,187

Reducing malaria in pregnancy through focal drug administration in household members: A pilot feasibility trial

open
May 31, 2026$123,118 - $123,118

Early Life B-cell and plasma cell development in the human Spleen: a new paradigm for lifelong immunity

open
May 31, 2030$778,829 - $778,829

Unraveling the spectrum of intrabacterial amide hydrolysis to develop new classes of pyrazinoic acid prodrugs against pyrazinamide resistant Mycobacterium tuberculosis

open
May 31, 2030$813,373 - $813,373

Dissecting the role of CD38 and metabolism in the heightened Treg potential of human neonatal naïve CD4+ T cells

open
Jun 2, 2027$47,767 - $47,767

IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV Remission

open
May 31, 2030$800,389 - $800,389

Developing Novel Tools for Precision Targeting of Pro-Autoimmune Th17 Cells

open
May 31, 2027$166,000 - $166,000

Planning for Na-GST-1 Hookworm Vaccine Phase 2 CHIM Efficacy Trial

open
May 31, 2026$242,058 - $242,058

Dissecting the molecular targets to overcome beta-lactam resistance in M. abscessus complex

open
May 31, 2030$901,706 - $901,706

Uncovering mechanisms of nitric oxide detoxification and reactivity in Pseudomonas aeruginosa

open
May 31, 2027$158,000 - $158,000

A Novel Cost-Effective Multispecific Therapeutic for Dengue

open
May 31, 2026$294,583 - $294,583

An unconventional regimen comprising biofilm disruptor as an adjunct with antibiotics to treat Mycobacterium abscessus chronic lung disease

open
May 31, 2027$155,227 - $155,227

Exploiting a high-precision phenotypic map to illuminate environmental sensing by a fungal meningitis pathogen

open
May 31, 2030$616,588 - $616,588

The Effects of Doxycycline on Inflammation and the Microbiome: 'Flipping the Script' on STI PEP

open
May 31, 2030$797,734 - $797,734

Human antibodies as broad alphavirus immunotherapeutics

open
May 31, 2030$843,620 - $843,620

Development of Conformer-Specific Anti-I-A Class II mAbs

open
May 31, 2027$164,000 - $164,000

Solving the puzzle of beta-1,6-glucan in the cryptococcal cell wall

open
May 31, 2030$773,053 - $773,053

Host Regulation of Flavivirus Infection

open
May 31, 2030$530,385 - $530,385

Phage-Polymer Nanoparticles for Treatment of Antibiotic-Recalcitrant Wound Biofilm Infections

open
May 31, 2030$593,860 - $593,860

STING induced IFNL2/3 protects human intestinal epithelial cells from rotavirus infection

open
May 31, 2030$502,248 - $502,248

A multipronged, mRNA gene therapy approach to HIV cure

open
May 31, 2030$486,057 - $486,057

Systemic and gastrointestinal targeted CDPK1 inhibitors for cryptosporidiosis

open
May 31, 2030$812,603 - $812,603

Virus and Host Directed Immunotherapies for Cure in SHIV-infected Infant Macaques

open
May 31, 2030$1,332,155 - $1,332,155

Study the role of ICOS on murine and human ILC2s

open
May 31, 2030$590,711 - $590,711

Pre-clinical studies to repurpose FDA-approved adenosine A2A receptor antagonists for lethal rickettsial infection

open
May 31, 2030$463,698 - $463,698

Defining macrophage defense during Klebsiella pneumoniae bacteremia

open
May 31, 2027$249,000 - $249,000

Characterizing the Neonatal Nasal Microbiome Following a Parent-to-Child Nasal Microbiota Transplant

open
May 31, 2027$401,191 - $401,191

Investigating Lipid-gene Molecular Profiles of Septic ARDS

open
May 31, 2027$424,223 - $424,223

Functions of mRNPs in RNA metabolism in Plasmodium falciparum

open
May 31, 2030$375,000 - $375,000

DNA Binding Dynamics and Oligomerization of Sensors of the PYHIN family in Pattern Recognition

open
May 31, 2028$556,427 - $556,427

Novel B cell epitope discovery against human coronaviruses

open
May 31, 2030$899,935 - $899,935

Mycobacterium tuberculosis disease effect on HIV-1 immunity, evolution, and persistence

open
May 31, 2026$711,993 - $711,993

Injectable 3D-Clustered Human Fibroblastic Reticular Cells for Expanding Regulatory T Cells

open
May 31, 2027$231,131 - $231,131

Molecular Programs Governing Enterococcal Translocation

open
May 31, 2030$828,820 - $828,820

Decoding mechanisms of early life inflammation

open
May 31, 2030$797,735 - $797,735

Bridging cell and organism scales to model viral, cell, and microenvironmental determinants of infection outcome

open
May 31, 2030$812,397 - $812,397

Lymphatic control of germinal centers

open
May 31, 2030$806,693 - $806,693

The Role of Tbet+ B cells in viral reinfection

open
May 31, 2027$416,121 - $416,121

Testing the contribution of ex-Tregs to autoimmunity and cancer immunity

open
May 31, 2027$441,202 - $441,202

Self Assembled Peptide Nanoparticles as Multi-Antigen Universal Influenza Vaccines

open
May 31, 2030$390,942 - $390,942

Effects of Vaccination on Acute and Post-Acute Respiratory Viral Infection Outcomes in Solid Organ Transplant Recipients

open
May 31, 2030$1,442,898 - $1,442,898

Developing new antifungals against sterolglycosidases

open
May 31, 2030$782,178 - $782,178

Decoding the polymicrobial interactions in bile acid metabolism by the gut microbiome.

open
Jun 11, 2028$37,731 - $37,731

Cellular Identity of the Intact HIV Reservoir

open
May 31, 2027$489,500 - $489,500

Clinical Research Products Management Center (CRPMC)

open
Jun 15, 2026$8,628,931 - $8,628,931

Characterization of Allogeneic T Cells Mediating HIV Cure

open
May 31, 2030$1,657,972 - $1,657,972

Host-pathogen interactions during Staphylococcus aureus spine infections

open
May 31, 2030$208,332 - $208,332

Defining the Structure and Function of a New Family of Peptidoglycan Crosslinking Enzymes

open
May 31, 2030$661,693 - $661,693

A membrane fusion apparatus trailblazes measles virus spread in airway cells

open
May 31, 2027$427,625 - $427,625

Regulation of Chlamydial Divisome Assembly

open
May 31, 2030$782,795 - $782,795

A CRISPR based organoid screen for mediators of epithelial-myeloid interactions

open
May 31, 2027$453,750 - $453,750

Manipulation of antibody responses by a retrovirus

open
May 31, 2027$451,000 - $451,000

Novel Integrative Analysis of Microbiome and Host Genetics in Childhood Asthma Research

open
May 31, 2030$597,904 - $597,904

TGFβ Restricts Tfh2 Differentiation but Augments IgE-Mediated Mast Cell Function: Critical and Opposing Roles in Allergic Disease

open
May 31, 2027$162,000 - $162,000

Non-viral gene therapy with eCD4-Ig

open
May 31, 2026$917,294 - $917,294

Elucidating Novel Mechanism of HIV-1 Evading APOBEC3G Antiviral Function Through Selective Viral RNA Packaging

open
May 31, 2027$400,125 - $400,125

Johns Hopkins HIV Implementation Science Hub (Hopkins Hub)

open
May 31, 2030$773,365 - $773,365

Rapid Antigen Test for Diagnosis of Active HCV Infection

open
May 31, 2027$272,133 - $272,133

Adipocyte-Eosinophil Communication and Its Role in Regulation of Airway Function

open
May 31, 2030$730,392 - $730,392

Development of a Human Lymph node-on a Chip Microphysiological System for Evaluation of Vaccine Effectiveness against Infectious Diseases

open
May 31, 2027$437,477 - $437,477

Role of Merkel cell polyomavirus small T antigen in persistent infection

open
May 31, 2030$634,981 - $634,981

Autoimmunity, calorie restriction, and core body temperature

open
May 31, 2027$541,500 - $541,500

Cellular mechanisms of macrophage activation syndrome

open
May 31, 2030$188,772 - $188,772

Evaluating the safety, immunogenicity and efficacy of a robust attenuated Mtb vaccine in the setting of HIV co-infection

open
May 31, 2030$905,998 - $905,998

Role of HMGB1 in an experimental model of Bacterial ligand induced Vasculitis

open
May 31, 2027$459,250 - $459,250

Center for accelerated development of drug candidates targeting high threat bacterial infections

open
May 31, 2030$7,562,521 - $7,562,521

Dissecting the mechanism of altered immune responses during obesity

open
May 31, 2027$425,647 - $425,647

Deciphering innate and adaptive immune responses to Rickettsia parkeri

open
May 31, 2030$745,295 - $745,295

Fine-resolution genetic mapping of advanced intercross lines of Biomphalaria glabrata

open
May 31, 2027$430,251 - $430,251

Role of TXLNA in cytosolic DNA-mediated innate immunity

open
May 31, 2030$382,500 - $382,500

Synoviocyte endothelial cell cross talk in rheumatoid arthritis

open
May 31, 2027$459,250 - $459,250

Mechanistic Investigation of a Rotavirus Auxiliary Protein NSP6 Countering Host Defense

open
May 31, 2030$593,021 - $593,021

The anatomy of T-cell mediated neutrophil recruitment during lung infection

open
May 31, 2027$472,210 - $472,210

IND-enabling development of MM-009, a reservoir-intravaginal ring for ultra-highrates of month-long lactic acid release to treat and prevent bacterial vaginosis

open
May 31, 2028$1,025,000 - $1,025,000

Therapeutic Mechanisms of Farnesol in Modulating Gut Dysbiosis and Neuroinflammation in Multiple Sclerosis

open
May 31, 2028$418,493 - $418,493

Evaluating the impact of pre-existing humoral immunity on hepatocyte death

open
May 31, 2027$516,175 - $516,175

Advancing mosquito blood-feeding rate quantification using micro-CT imaging: an innovative tool for vector-borne disease transmission studies

open
May 31, 2027$135,107 - $135,107

Buy the world a coke and keep it mosquito free

open
May 31, 2027$433,303 - $433,303

Isothermal DNA amplification using double DNA primer

open
May 31, 2027$151,496 - $151,496

NIAID VIROLOGY QUALITY ASSURANCE (VQA)

open
Jun 20, 2026$3,434,765 - $3,434,765

Lytic viral genes in the pathogenesis of oncogenic gammaherpesviruses

open
May 31, 2027$420,335 - $420,335

A less resource-intensive mouse model of M. abscessus lung disease

open
May 31, 2027$426,938 - $426,938

Predicting Viral Spillover Risk using Machine Learning and Adversarial Mutation

open
May 31, 2027$422,814 - $422,814

A chromatin structure informed exploration of gene regulation in Anopheles coluzzii

open
May 31, 2027$429,000 - $429,000

Biomaterial technologies to train innate immunity

open
May 31, 2027$425,226 - $425,226

Identifying the Determinants of Persister Cell Survival in M. tuberculosis.

open
May 31, 2027$404,108 - $404,108

Mingling life imaging and cell subpopulations expression analysis in NHP lungs targeted with exosome associated double AAV vectors

open
May 31, 2027$437,250 - $437,250

Understanding heterogeneity of necroptotic cell death and mechanism(s) of necroptosis escape

open
May 31, 2027$450,764 - $450,764

Development of novel antibodies to autoreactive B cells as a potential therapeutic for SLE patients

open
May 31, 2027$423,500 - $423,500

Revealing the Role of Lipid-Laden Macrophages in Staphylococcus aureus Osteomyelitis Abscess Formation

open
Jun 30, 2027$34,880 - $34,880

Genetic basis of incomplete penetrance of RPSA haploinsufficiency for congenital asplenia

open
Jun 30, 2027$466,125 - $466,125

The role of VacA in Helicobacter pylori-host cell cholesterol homeostasis

open
Jun 30, 2028$49,538 - $49,538

The Role of Xist in T Cell Activation and Female-Biased Autoimmunity

open
Jun 30, 2027$46,207 - $46,207

Alphavirus determinants of microvascular endothelial cell infection

open
Jun 30, 2027$254,250 - $254,250

Immunometabolite L-2-Hydroxyglutarate in Natural Killer Cell Antiviral Immunity

open
Jun 30, 2029$54,538 - $54,538

Structural Basis for HIV-1 Rev Nucleocytoplasmic Trafficking

open
Jun 30, 2028$43,193 - $43,193

Novel TNF Secretion Assays

open
Jun 30, 2027$149,041 - $149,041

Type 2 Immune Responses in Endotoxemia-induced Lung Injury

open
Jun 30, 2027$486,109 - $486,109

Systematic identification of interactions between Lyme Borrelia and Ixodes scapularis

open
Jun 30, 2027$461,375 - $461,375

Macrophage-derived nanoparticles as an adjuvant therapy for severe bacterial pneumonia

open
Jun 30, 2029$43,049 - $43,049

Chemical Probes of Complement Pathways

open
Jun 30, 2027$407,156 - $407,156

High throughput identification of bacteriophages and their hosts with single-cell transcriptomics

open
Dec 31, 2027$36,046 - $36,046

Innate immune regulation of mAb-induced infusion reactions

open
Jun 30, 2027$431,147 - $431,147

Norepinephrine-mediated resistance to nutritional immunity in Neisseria gonorrhoeae

open
Jun 30, 2029$38,945 - $38,945

Elucidating the role of fimbriae in Klebsiella pneumoniae-mediated liver abscess formation

open
Jun 30, 2027$427,625 - $427,625

Novel Antivirals Targeting Lenacapavir-Resistant HIV

open
Jun 30, 2029$49,538 - $49,538

RANKL regulation of human B cell responses

open
Jun 30, 2026$88,360 - $88,360

Novel Mechanisms of CD4-Independent Immunity Against Pneumocystis

open
Jun 30, 2027$226,500 - $226,500

Age-associated changes in B cell and antibody effector responses to Streptococcus pneumoniae

open
Jun 30, 2028$49,538 - $49,538

The Cell Biology of HIV-1 Genome Trafficking

open
Jun 30, 2030$376,863 - $376,863

Extent, dynamics and mechanisms of Plasmodium vivax immune evasion caused by PvDBP gene amplification

open
Jun 30, 2028$63,525 - $63,525

Once Bitten: Acquisition of Malaria Adaptive Immunity (OBAMA - Immunity)

open
Jun 30, 2028$154,153 - $154,153

Integrating single-cell omics and ancestry-adjusted eQTL mapping to characterize Tuberculosis immune response

open
Jun 30, 2026$43,200 - $43,200

Control of CD8+ T cell Memory Homeostasis via Extracellular Damage Sensors ARTC2 & P2RX7

open
Jun 30, 2026$90,964 - $90,964

Sustained release of VRC07 from capsule-intravaginal ring for preventing HIV transmission

open
Jun 30, 2026$306,183 - $306,183

Targeted antibiotic therapy for Shigella among children in low-resource settings

open
Jun 30, 2029$140,429 - $140,429

Liposomal Amphotericin B and Flucytosine Antifungal Strategies for Talaromycosis (LAmB-FAST)

open
Jun 30, 2031$531,188 - $531,188

The effect of HIV on SARS-CoV-2 transmission and emergence of variants of concern

open
Jun 30, 2026$201,406 - $201,406

Characterization of cAMP signaling microdomains in the human pathogen Trypanosoma cruzi

open
Jun 30, 2027$444,688 - $444,688

Contribution of C4b-binding protein to interactions of Neisseria gonorrhoeae with human neutrophils

open
Jun 30, 2028$38,922 - $38,922

Evaluation of High-throughput Extracellular Vesicle Loading Platform for Therapeutic Genome Editing INDs

open
May 1, 2028$452,378 - $452,378

Innovative Antibiotic Combinations for Hypervirulent Klebsiella pneumoniae

open
Jun 30, 2027$456,911 - $456,911

Type 5 secretion as a novel mechanism to deliver protein effectors directly into mammalian host cells

open
Jun 30, 2027$410,497 - $410,497

Innate memory signaling in airway epithelial cells

open
Jun 30, 2027$235,500 - $235,500

Structural and Biochemical Studies of HIV and MMTV Retroviral Integration onto Nucleosome-bound Target DNA

open
Jun 30, 2028$47,475 - $47,475

Enhancing Surveillance Methods for Genomic Epidemiology in Healthcare

open
Jun 30, 2030$128,655 - $128,655

Basic immunological toolbox for genus Peromsycus, infection tolerant reservoirs of zoonotic agents

open
Jun 30, 2027$431,750 - $431,750

Gamma herpesvirus impact on required B cell:CD4 T interactions in a B cell-dependent, antibody-independent mouse model of multiple sclerosis

open
Jun 30, 2027$427,627 - $427,627

Development of an improved transposon mutagenesis system for comprehensive genetic analysis of Borrelia burgdorferi

open
Jun 30, 2027$165,000 - $165,000

Innate Cells with Adaptive Specificity: Bond Kinetics of NK Cell Inhibitory Receptor Ly49C

open
Jun 30, 2028$78,040 - $78,040

Characterization of Plasmodium falciparum long non-coding RNAs and their roles in gene regulation

open
Jun 30, 2027$445,488 - $445,488

The evolutionary genetic basis for changes in viral receptor-binding specificities

open
Jun 30, 2028$41,963 - $41,963

Modulation of cytomegalovirus replication by the viral temperance factor RL13

open
Jun 30, 2027$426,939 - $426,939

PET to Assess Post-TB Lung Disease in TB Patients with / without HIV coinfection

open
Jun 30, 2027$445,500 - $445,500

Mechanisms of sigma-factor-dependent transcriptional control in Mycobacterium tuberculosis

open
Jun 30, 2028$75,520 - $75,520

Bacterial and Host Heterogeneity in TB latency, persistence and progression

open
Jun 30, 2026$38,013 - $38,013

Enhancing immunity to malaria in young children with effective chemoprevention

open
Jun 30, 2027$513,257 - $513,257

MEPCS (Multi-epitope protease cleavage sites) vaccine for protecting against SIV rectal transmission

open
Jun 30, 2029$657,563 - $657,563

A Structural and Functional Interrogation of the Ligand-Independent Signaling Properties of the IgE BCR

open
Jun 30, 2028$49,538 - $49,538

Innovative Tools to Expand HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs)

open
Jun 30, 2029$93,646 - $93,646

Contribution of RpoS to persistence of Borrelia burgdorferi in mammals

open
Jun 30, 2027$457,875 - $457,875

The role of the spleen in maintaining immune tolerance to transplanted islets

open
Jun 30, 2027$423,500 - $423,500

Alveolus on a chip model of non-tuberculous mycobacteria infection

open
Jun 30, 2027$451,000 - $451,000

Development of Diagnostic Antibodies for Acute and Chronic Chagas Disease

open
Jun 30, 2027$449,408 - $449,408

A 3-In-One Design of CAR Tregs for Robust Immunotolerance

open
Jun 30, 2027$423,500 - $423,500

Molecular Tailoring of Bispecific Antibody–BottlebrushConjugates

open
Jun 30, 2027$386,194 - $386,194

Virus-host interactions regulating innate signaling for human cytomegalovirus latency

open
Jan 31, 2027$384,698 - $384,698

Dynamic and functional analysis of Enterococcus faecalis penicillin binding protein 4 pedestal domain

open
Jun 30, 2030$51,628 - $51,628

A new deep learning approach to probe the molecular basis of inhalation allergens

open
Jun 30, 2027$440,000 - $440,000

Myobacterium tuberculosis Phenylalanine Synthesis as a Novel Drug Target

open
Jun 30, 2027$423,500 - $423,500

Identification of Cross-Protective Surface Antigens in Burkholderia Species

open
Jun 30, 2027$38,936 - $38,936

Role of Carbon Metabolism and Virulence of Shigella flexneri

open
Jun 30, 2030$391,709 - $391,709

Development of novel model to measure TCR signal strength in dual TCR cells

open
Jun 30, 2027$159,500 - $159,500

Antibody feedback on B cell response to vaccination

open
Jun 30, 2029$36,673 - $36,673

Microbiology of Post-Treatment Lyme Disease Syndrome

open
Jun 30, 2029$495,862 - $495,862

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline

open
Jun 30, 2028$97,524 - $97,524

Inflammation and Fibrosis in Pulmonary TB: the INFIN-TB Study

open
Jun 30, 2027$335,986 - $335,986

Harnessing the Malarial Immunity Omics Landscape in Vaccinated and Unvaccinated Children for Improved Therapeutic Strategies

open
Jun 30, 2029$232,955 - $232,955

Development of mosaic enterovirus mRNA vaccine to prevent hand, foot and mouth disease

open
Jun 30, 2027$433,175 - $433,175

Structural Studies of Helicobacter Pyloris Cag Type IV Secretion System

open
Jun 30, 2028$80,224 - $80,224

Investigation of the role(s) chlamydial polymorphic membrane proteins (Pmps) play during infection with C. trachomatis

open
Jun 30, 2027$423,500 - $423,500

Introducing a novel computational framework for B-cell epitope prediction based on immune-induced selection signatures

open
Jun 30, 2027$406,260 - $406,260

Cell-type-specific Evaluation of Liver Allografts during Normothermic-Machine-Perfusion

open
Jun 30, 2027$429,000 - $429,000

Investigating a hemagglutinin mediated molecular mechanism of avian influenza A virus host tropism

open
Jun 30, 2027$49,538 - $49,538

Architecture of a divergent bipartite internal ribosome entry site from Giardiavirus

open
Jun 30, 2027$518,400 - $518,400

Use of random barcode transposon site sequencing as a tool for identifying nutrient acquisition strategies utilized by Mycobacterium tuberculosis during infection of human macrophages

open
Jun 30, 2027$227,096 - $227,096

The role of Salmonella Typhi virulence factors in systemic dissemination

open
Jun 30, 2029$42,895 - $42,895

Investigating the role of type 1 interferon signaling on vaccine stability within lymphatic endothelial cells

open
Jun 30, 2027$38,558 - $38,558

Defining mechanistic drivers of impaired B cell response to influenza A virus vaccine under conditions of obesity

open
Jun 30, 2027$75,052 - $75,052

Mechanical deformation of the cell envelope as a form of surface-sensing in Pseudomonas aeruginosa

open
Jun 30, 2028$80,020 - $80,020

Immunomodulatory effects of interferon lambda on infant neutrophils

open
Jun 30, 2027$416,199 - $416,199

Advancing Transplantation Outcomes in Children

open
Jun 30, 2028$66,028 - $66,028

Deciphering the impact of sex in early subtype C HIV infection and during HART

open
Jun 30, 2027$63,564 - $63,564

Inhibition of lipoprotein synthesis in Helicobacter pylori

open
Jun 30, 2027$481,250 - $481,250

Leptospira prevalence, cycling, and infection in the peridomestic environment

open
Jun 30, 2028$146,890 - $146,890

Isolation of broadly protective monoclonal antibodies for Crimean Congo Hemorrhagic Fever

open
Jun 30, 2029$58,536 - $58,536

Uncovering the mechanisms and implications of BST2 antagonism by SARS-CoV-2

open
Jun 30, 2028$49,538 - $49,538

Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation

open
Jun 30, 2029$50,000 - $50,000

Characterization of a ubiquitin binding domain in interferon pathway protein RIOK3

open
Jun 30, 2027$143,094 - $143,094

Characterizing the Renal Immune Microenvironment in Antibody-Mediated Rejection to Predict Treatment Response using Imaging Mass Cytometry

open
Jun 30, 2026$76,756 - $76,756

Bacterial and host determinants of progression, manifestations and consequences of TB

open
Jun 30, 2026$8,125 - $8,125

A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure for Individuals on TLD in Sub-Saharan Africa

open
Jun 30, 2027$278,479 - $278,479

Innovative approaches to enhance regulatory immune cell function and renal transplant survival in nonhuman primates

open
May 31, 2030$1,455,073 - $1,455,073

Adaptive immune responses in bats

open
Jun 30, 2030$452,475 - $452,475

Effects of a chromosomal inversion on gene regulation in a major malaria vector

open
Jun 30, 2029$51,628 - $51,628

Evaluation of Immunodominant fragments of PfGARP for malaria vaccine development

open
Jun 30, 2027$412,500 - $412,500

Tobacco Mosaic Virus as a mucosal delivery platform for an intranasal vaccine against Pseudomonas aeruginosa

open
Jun 30, 2027$261,846 - $261,846

Gene regulatory network of memory B cell and long-lived plasma cell differentiation

open
Jun 30, 2030$625,348 - $625,348

Zoonotic Uropathogenic Escherichia coli in Northwest Ecuador: Incidence and Risk Factors

open
Jun 30, 2027$158,314 - $158,314

PB1-F2 mediates hypoxemia in influenza

open
Jun 30, 2027$433,125 - $433,125

Determining function and mechanism of lncRNA Chast in Trypanosoma cruzi infection and dissemination

open
Jun 30, 2027$440,000 - $440,000

Molecular mechanisms of signal transduction by the Campylobacter jejuni BumSR two-component system

open
Jun 30, 2027$451,000 - $451,000

Defining correlates of protection from dengue illness in a long-term cohort study of multigenerational house-holds in Thailand

open
Jun 30, 2028$94,253 - $94,253

3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology

open
Jun 30, 2027$1,000,000 - $1,000,000

Elucidating astrovirus egress and the effects of infection on gut homeostasis

open
Sep 30, 2027$42,788 - $42,788

The role of pH in the pathogenesis of type 1 diabetes

open
Jun 30, 2027$429,000 - $429,000

Exploiting a multiplex HTS assay to identify novel boron-based inhibitors of mycobacterial class II aminoacyl-tRNA synthetases

open
Jun 30, 2027$415,978 - $415,978

MSP68 as an effective radiation countermeasure

open
Jun 30, 2027$167,500 - $167,500

HIV-1 Fusion on Native Membranes Captured by Cryo-Electron Tomography

open
Jun 30, 2030$603,338 - $603,338

FOXN1 variant regulation of T cell production

open
Jun 30, 2027$436,466 - $436,466

Genetic Regulation of Factor VIII Inhibitor Development

open
Jun 30, 2027$470,553 - $470,553

Bringing alloreactivity into focus with the lens of TCR cross-reactivity

open
Jun 30, 2027$459,439 - $459,439

In vivo and ex vivo gene editing for Artemis-deficient SCID

open
Jun 30, 2027$420,771 - $420,771

From inhibitors to enzymatic deficiencies: exploring alterations in erythrocyte glycolysis as an antimalarial strategy.

open
Jun 30, 2030$187,056 - $187,056

Designing better T cell epitopes for improved T cell vaccines and therapies

open
Jun 30, 2027$462,000 - $462,000

Control of regulatory T cell fitness and function by heme synthesis

open
Jun 30, 2030$647,187 - $647,187

New potent orally bioavailable nitro-containing compounds to treat mycobacterial infections

open
Jun 30, 2028$2,248,740 - $2,248,740

Individualized HIV Curative Combination Strategy against Persistent HIV on ART

open
May 31, 2030$3,568,644 - $3,568,644

IAS 2025. the 13th IAS Conference on HIV Science, Kigali, Rwanda, 14-17 July 2025

open
Jun 30, 2026$940,000 - $940,000

The Role of Ariadne RBR E3 ubiquitin protein ligase 2 (ARIH2) in influenza A virus replication and pathogenesis in the airway epithelial cells

open
Jun 30, 2030$605,778 - $605,778

Regulation of neutrophil plasticity, heterogenicity, and functional ambivalency by WNT5 in colitis

open
Jun 30, 2029$2,685,326 - $2,685,326

Regulation of the cGAS-STING pathway by RNF11

open
Jun 30, 2027$425,004 - $425,004

Investigating the role of T cells in promoting post-acute memory deficits after COVID-19 in mice

open
Jun 30, 2027$107,995 - $107,995

Bacterial cell wall remodeling, innate immunity, and pathogenesis

open
Jun 30, 2029$2,841,668 - $2,841,668

Sequence specific determinants, and impacts, of NS2 interactions with the influenza A virus polymerase

open
Jun 30, 2027$438,500 - $438,500

Mechanisms that underpin immunoglobulin gene rearrangement

open
Jun 30, 2027$438,500 - $438,500

Sex differences in a cytokine controlling antibody class switch recombination

open
Jul 7, 2027$439,088 - $439,088

Metabolic targeting of CD4 T cells in CNS autoimmunity

open
Jun 30, 2030$790,222 - $790,222

B cell receptor dependent infection as a mechanism of immune-mediated enhancement of dengue virus infection and pathogenesis

open
Jun 30, 2030$649,530 - $649,530

Contributions of BRWD1-mediated cohesin conversion to B cell biology

open
Jun 30, 2029$3,018,216 - $3,018,216

Human cutaneous responses to arthropod-mediated viral transmission

open
Jul 7, 2027$449,625 - $449,625

A Unique Device to Measure Radiation Dose and Homogeneity of Exposure Following a Large-Scale Ionizing Radiation Event

open
May 31, 2030$350,000 - $350,000

The multifaceted roles of PI(4,5)P2 on HIV-1 assembly

open
Jun 30, 2027$132,300 - $132,300

Formation of a Novel SARS-CoV-2 Nucleocapsid Dimer: Impacts on Viral and Cellular Processes

open
Jun 30, 2027$438,983 - $438,983

Phage-Seq phenotyping of the Pseudomonas aeruginosa surface-ome

open
Jun 30, 2027$453,629 - $453,629

Microbiota-mediated colonization resistance to Acinetobacter baumannii.

open
Jun 30, 2030$582,350 - $582,350

Role of cholinergic neuroimmune signaling pathway disruption in the pathogenesis of Hirschsprung-associated enterocolitis

open
Jul 7, 2027$439,216 - $439,216

Develop novel iNOS/NO inhibitors for mitigating inflammatory cell death, ARDS, and MODS

open
Jun 30, 2027$385,625 - $385,625

Kinase activity rewiring in T cell trans-differentiation

open
Jun 30, 2027$464,750 - $464,750

Study the Treg-IL-27 axis in immune regulation

open
Jun 30, 2029$3,022,197 - $3,022,197

Bioinspired Point of Care Testing for HIV/HBV Co-infection

open
Jun 30, 2030$354,570 - $354,570

Understanding the influence of climate and other environmental factors on blastomycosis incidence and seasonality in northern Great Lakes states

open
Jun 30, 2027$419,274 - $419,274

Long-lived highly differentiated monocyte-derived cells (LDMs) activate lung-resident CD8+ T cell memory

open
Jun 30, 2027$415,250 - $415,250

Role of post-sepsis exercise therapy in regulating CD4 T cell immunity against secondary Pseudomonas aeruginosa infection

open
Jun 30, 2027$460,625 - $460,625

Development of siRNA-peptide libraries for delivery screening

open
Jun 30, 2027$506,000 - $506,000

Cellular Determinants of HCMV infection

open
Jun 30, 2030$525,095 - $525,095

Determinants of pegivirus persistence and immune control

open
Jun 30, 2030$692,689 - $692,689

A synthetic miR-7702: a potential therapeutic approach for SARS-CoV-2 infection

open
Jun 30, 2027$411,400 - $411,400

Uncovering the role of BND2 cells in autoimmunity

open
Jun 30, 2030$634,984 - $634,984

Single-cell phenotyping for better drug discovery

open
Jun 30, 2027$461,250 - $461,250

EV-D68 genetic neuropathogenesis determinants

open
Jun 30, 2027$430,170 - $430,170

The role of cryptic influenza virus proteins in replication and pathogenesis

open
Jun 30, 2029$3,085,097 - $3,085,097

Defining the impact of type 1 cytokine signaling on STAT-mediated epithelial reprogramming and barrier dysfunction in eosinophilic esophagitis

open
Jun 30, 2029$3,375,359 - $3,375,359

Natural Killer Cell Recruitment and Differentiation

open
Jun 30, 2027$223,068 - $223,068

How SAMHD1 regulates HIV-1 innate immunity and viral gene expression

open
Jun 30, 2030$769,414 - $769,414

Training of Neutrophils to Defend Against a Lethal Bacterial Infection of the Lung

open
Jun 30, 2027$430,760 - $430,760

Gardnerella promotion of N. gonorrhoeae pathogenesis

open
Jun 30, 2027$243,750 - $243,750

Notch regulation of airway epithelial-immune cell cross-talk in SARS-CoV-2 infection

open
Jun 30, 2027$448,688 - $448,688

Development of new tools to study how T. gondii rhoptry effector proteins are delivered into host cells during invasion

open
Jun 30, 2027$408,865 - $408,865

Overcoming obstacles in structural elucidation of B cell antigen receptor assembly and lateral interaction

open
Jun 30, 2027$489,500 - $489,500

Cell intrinsic antiviral immunity in diverse bats

open
Jun 30, 2030$454,726 - $454,726

Identifying novel immune determinants that influence S. aureus biofilm infection using Collaborative Cross (CC) mouse lines

open
Jun 30, 2027$417,845 - $417,845

Mechanisms of antagonism of BST2 isoforms and implications for HIV pathogenesis

open
Jun 30, 2030$368,750 - $368,750

Metabolic Regulation by SAPS3 of Virus-specific T cell Immunity

open
Jun 30, 2029$2,832,747 - $2,832,747

Harnessing phage resistance mechanisms for optimization of antibiotic therapy in mycobacteria

open
Jun 30, 2027$408,375 - $408,375

Characterization of Homotypic Fusion in Chlamydia muridarum

open
Jun 30, 2027$156,000 - $156,000

Hyaluronidase mediated GBS Disease

open
Jun 30, 2029$3,613,118 - $3,613,118

Microbial Programming of T-cell Migration from Gut to Brain

open
Jun 30, 2029$4,908,988 - $4,908,988

Determining the role of 90K on SARS-CoV-2

open
Jun 30, 2027$437,895 - $437,895

Mouse model of neonatal fungal colonization to study homeostasis and disease

open
Jun 30, 2027$245,250 - $245,250

B cell-dependent regulatory T cells

open
Jun 30, 2030$807,799 - $807,799

Advancing a Platform Technology for C. difficile Infection Treatment: the Promise of Antisense Oligonucleotides

open
Jun 30, 2027$426,875 - $426,875

Regulation of infectious spore formation in the fungal pathogen Coccidioides posadasii

open
Jun 30, 2027$438,038 - $438,038

Elucidating fungal and bacterial polymicrobial interactions during catheter-associated urinary tract infections

open
Jun 30, 2027$234,750 - $234,750

Colorado State University StARR Program in Infectious Disease and Immunology

open
Jun 30, 2030$209,164 - $209,164

Investigating the Metabolic Role of the Redox Cofactor F420 in Mycobacterium tuberculosis Hypoxic Persistence

open
Jul 14, 2029$54,538 - $54,538

Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services

open
Jul 14, 2026$66,177 - $66,177

Glycopolymers as Cellular Glues

open
Jul 14, 2028$49,538 - $49,538

Development of a radiation countermeasure with sex-dependent radiation response.

open
Jun 30, 2027$170,800 - $170,800

Protective roles of CD180 and NOD1 in the protective immunity against cerebral Toxoplasma infection

open
Jun 30, 2027$423,500 - $423,500

The Ferret as a model for evaluation of antiviral efficacy against Venezuelan equine encephalitis virus

open
Jun 30, 2027$423,500 - $423,500

Defining STING Interactions that are Required for Rhinovirus Replication

open
Jun 30, 2027$423,803 - $423,803

Single cell analysis of dysregulated inducible DNA amplifications of immune response genes in Down syndrome

open
Jun 30, 2027$234,000 - $234,000

Human rotavirus egress and infection in association with extracellular vesicles

open
Jun 30, 2027$481,250 - $481,250

Investigating the contribution of a novel monocyte transcriptional state to sepsis immunopathogenesis and patient heterogeneity

open
Jun 30, 2030$197,640 - $197,640

Determining the contribution of glutaminase-dependent metabolism of dendritic cells to inflammatory diseases

open
Jun 30, 2030$751,138 - $751,138

Roles and regulation of tissue resident CD8 T cells during a persistent viral infection

open
Jun 30, 2029$3,194,992 - $3,194,992

Placating death eaters: Tuning macrophage metabolism and phenotype via nanoparticles

open
Jun 30, 2027$152,250 - $152,250

Investigating the development and regulation of the extrafollicular B cell response as a programmed response type

open
Jun 30, 2030$556,843 - $556,843

Targeting Multidrug-Resistant Pseudomonas aeruginosa with R Pyocins

open
Jun 30, 2027$439,896 - $439,896

Evaluation of the Mechanisms Underlying Induction and Maintenance Immunosuppression Impact on T Cell Function after Kidney Transplantation

open
Jun 30, 2029$3,106,301 - $3,106,301

Using proteomics to identify host cell death factors during M. tuberculosis infection

open
May 31, 2030$819,998 - $819,998

Maternal microbial exposure fundamentally shapes the CD8 T cell population at the maternal fetal interface

open
Jun 30, 2029$2,999,774 - $2,999,774

Dietary fat-activated colonocyte-macrophage ketone shuttle drives intestinal inflammation

open
Jun 30, 2029$2,893,480 - $2,893,480

Immune adaptations in acute pouchitis

open
Jun 30, 2027$409,320 - $409,320

Project 2: Development of vaccines in preclinical models to induce V2-apex bnAb responses

open
May 31, 2030$2,750,363 - $2,750,363

Mechanisms by which Glp-1 and Gip receptor signaling enhance airway epithelial barrier function

open
Jun 30, 2027$481,249 - $481,249

Defining the role of TRIM proteins in vector-borne bunyavirus infection

open
Jun 30, 2027$440,000 - $440,000

Inhibition of viral membrane fusion by interferon-induced proteins

open
Jun 30, 2029$2,297,892 - $2,297,892

Enhancing bacteriophage function with coevolution and synthetic biology

open
Jun 30, 2030$198,046 - $198,046

Effect of Borrelia burgdorferi-SIRPalpha Interaction on the Immune Response

open
Jun 30, 2027$429,000 - $429,000

Function of PfNCR1 at the PPM/PVM Interface

open
Jun 30, 2030$633,218 - $633,218

Interrogating NFKBID dependent humoral immunity to Toxoplasma gondii

open
Jun 30, 2027$435,875 - $435,875

Defining the mechanism of action of the broadly-active antiviral mosquito protein aBravo

open
Jun 30, 2027$401,185 - $401,185

Antibiotics, innate immunity, and dysbiosis in pediatric urticarial reactions

open
Jun 30, 2027$401,250 - $401,250

Innate iNKT Cells Shape Organ-Specific Pathogenesis in Plasmodium Infection

open
Jun 30, 2027$423,500 - $423,500

A cross-species signaling system in tick immunity and development

open
Jun 30, 2030$518,099 - $518,099

High Resolution, Whole Genome Tracking of Pathogen Transmission and Infection in the Neonatal ICU (NICU)

open
Jun 30, 2030$881,303 - $881,303

The dynamic interplay of human cells and Entamoeba histolytica during trogocytosis (cell-nibbling)

open
Jun 30, 2027$431,004 - $431,004

TIM-4 Signaling in NASH Liver Transplant Ischemia/Reperfusion Injury

open
Jun 30, 2027$433,125 - $433,125

The Road from Independence to Parasitism

open
Jun 30, 2027$418,016 - $418,016

Innate-adaptive immune bridging in gravidity-dependent immunity against placental malaria: a multi-omics approach

open
Jun 30, 2030$789,442 - $789,442

Biosynthetic and self-resistance investigations of kibdelomycin.

open
Jun 30, 2027$392,747 - $392,747

Development of an intein-based QF2 system for controllable protein expression in the nervous system of Aedes aegypti

open
Jun 30, 2027$423,125 - $423,125

Identification by High Throughput Screening of Inhibitors of the Mycobacterium tuberculosis ESX-1 and ESX-5 Type VII Secretion Systems – critical virulence determinants and novel drug targets

open
Jun 30, 2027$236,250 - $236,250

Multiplexed CRISPRa/i in primary immune cells to elucidate gene regulatory networks underpinning T cell development

open
Jun 30, 2027$405,497 - $405,497

Optimizing lipid RVn monophosphate prodrugs to maximize RVn-triphosphate delivery

open
Jun 30, 2029$3,082,513 - $3,082,513

Fungal Antigen Resources for Development of Vaccines and Diagnostics

open
Jun 30, 2030$1,193,457 - $1,193,457

Interrogating stress and viral shedding in a migratory bat model

open
Jun 30, 2027$376,932 - $376,932

Multimodal PET-CT imaging of SIVmac239 dynamics post-ART interruption

open
Jun 30, 2029$3,302,677 - $3,302,677

Autofluorescence is a tool to monitor radiation exposure and predict acute lethality

open
May 31, 2030$551,250 - $551,250

Therapeutic potential of mycobacteriophage LysB against Mycobacterium abscessus infections

open
Jun 30, 2030$689,051 - $689,051

TLE transcription cofactors in anti-viral and anti-tumor immunity

open
Jun 30, 2029$3,436,588 - $3,436,588

Conditional and female lethal approaches for mosquito control

open
Jun 30, 2030$588,514 - $588,514

Molecular mechanisms underlying persistent effects of early life exposure on lung function and remodeling

open
Jun 30, 2027$414,368 - $414,368

Decoding multidrug-resistant pathogen dynamics for clinically-relevant wastewater surveillance

open
Jun 30, 2030$534,000 - $534,000

Atlas of efflux and permeation determinants to advance antibacterial therapeutic discovery

open
Jun 30, 2030$1,120,070 - $1,120,070

Non-deletional CD8+ T cell tolerance

open
Jun 30, 2030$657,673 - $657,673

Next-Generation CMA/CMB Derivatives as Targeted Inhibitors of HIV Nef

open
Jun 30, 2029$3,110,884 - $3,110,884

New tools to facilitate drug discovery for pathogen proteasomes

open
Jun 30, 2027$438,500 - $438,500

Trypanosome flagellum structure, assembly, and mechanism

open
Jun 30, 2030$736,920 - $736,920

PD-1 BiKE: Targeting and Depleting PD-1 Positive Cells for Autoimmune Disease Treatment

open
Jun 30, 2027$423,500 - $423,500

Optimizing anti-microbial immunity by targeting Sts-1

open
Jun 30, 2029$3,125,627 - $3,125,627

Elucidating and targeting Siglec-9 function on mast cells

open
Jun 30, 2030$612,917 - $612,917

HIV-1 Integrase Interactions with Viral RNA

open
Jun 30, 2027$258,200 - $258,200

The role of the mRNA-based or Newcastle disease virus (NDV)-based vaccine platform in mucosal B cell priming and recirculation

open
Jun 30, 2027$464,750 - $464,750

Heterocyclic Inhibitors of QcrB as Novel Drugs for Infections Caused by Nontuberculous Mycobacteria

open
Jun 30, 2027$300,001 - $300,001

Viral mechanism for engaging lytic cycle promoting host transcription factors

open
Jun 30, 2027$402,150 - $402,150

Mechanistic studies of the complex regulation of the signaling histidine kinase GacS from Pseudomonas aeruginosa

open
Jun 30, 2027$422,355 - $422,355

Epigenetic Checkpoint Regulation of Naive T-cell Quiescence and Peripheral Tolerance

open
Jun 30, 2029$3,428,212 - $3,428,212

Mechanisms of age-related lung inflammation in pulmonary melioidosis

open
Jun 30, 2027$445,338 - $445,338

Molecular targets of the anti-apicomplexan compound, tartrolon E

open
Jun 30, 2027$423,500 - $423,500

Defining the Functions of Entero-Mammary T cells in Lactogenesis and Maternal-Offspring Immunity

open
Jun 30, 2030$562,500 - $562,500

Effect of Sneathia vaginalis on the amnion

open
Jun 30, 2027$404,273 - $404,273

Non-tuberculous Mycobacteria as triggers of Systemic Lupus Erythematosus

open
Jun 30, 2027$413,860 - $413,860

Role of branched-chain fatty acids in physiology and virulence of Staphylococcus aureus

open
Jun 30, 2029$3,021,822 - $3,021,822

Transmission dynamics and fitness of reemerging St. Louis encephalitis virus in mosquito vectors and West Nile virus naïve and immune avian reservoirs

open
Jun 30, 2029$3,161,373 - $3,161,373

Specialization and targeting of CD4+ tissue resident memory T cells in EAE

open
Jun 30, 2030$687,422 - $687,422

Mitigative effects of apigenin against gastrointestinal acute radiation syndrome (GI-ARS) in mice

open
Jun 30, 2027$158,500 - $158,500

Defining human xenoglycan-specific B cells

open
Jun 30, 2027$225,953 - $225,953

Elucidating the role of the SARS-CoV-2 ORF9b protein in virus replication

open
Jun 30, 2027$217,337 - $217,337

Salmonella-mediated delivery of Francisella type VI secretion system proteins as antigens to induce protective immunity

open
Jun 30, 2027$422,125 - $422,125

Understanding resistance and tolerance to nitroimidazoles in Mycobacterium tuberculosis

open
Jun 30, 2029$2,944,529 - $2,944,529

Understanding the Role of Tick Phospholipase A2 in Alpha-Gal Syndrome

open
Jun 30, 2027$235,822 - $235,822

Dual Role of TRPV2 in the STING-mediated innate immune response

open
Jun 30, 2029$2,129,684 - $2,129,684

Defining human and mouse non-canonical inflammasome responses to LPS

open
Jun 30, 2029$3,204,624 - $3,204,624

Identifying a protective role for interferon lambda in tuberculosis

open
Jun 30, 2027$413,002 - $413,002

Defining the interaction between adrenergic nerves and immune memory

open
Jun 30, 2030$555,120 - $555,120

Modulation of Neutrophil Function by Red Cell Exchange in SCD Patients

open
Jun 30, 2027$444,125 - $444,125

Role and Regulation of the Secreted Proteases of Staphylococcus aureus

open
Jun 30, 2030$480,522 - $480,522

Role of Mast cells in regulating inflammatory pathology of secondary lymphedema

open
Jun 30, 2027$497,136 - $497,136

Mechanism of inflammation in deficiency of adenosine deaminase 2

open
Jun 30, 2030$522,524 - $522,524

Antagonistic actions of IRF4 and BACH2 in regulating Germinal Center B cell fates and promoting Lymphomagenesis

open
Jun 30, 2027$441,098 - $441,098

Role of the ETS1 proto-oncogene protein in polyomavirus transcription

open
Jun 30, 2027$240,150 - $240,150

Health and Environmental Impacts of a Citywide Sanitation Intervention in Indiana

open
Jun 30, 2027$237,750 - $237,750

Harnessing translational research to advance understanding and clinical care in antibiotic allergy

open
Jun 30, 2027$443,527 - $443,527

Identification and enrichment of signature regions of antimicrobial resistant pathogen genomes for wastewater disease surveillance

open
Jun 30, 2027$421,673 - $421,673

Mechanisms of Immediate Non-IgE-mediated Drug Hypersensitivity Reactions (MIND-HR)

open
May 31, 2027$426,048 - $426,048

Creating an improved oncolytic virus through directed evolution and virus-driven expression of a cancer-targeting peptid

open
Jun 30, 2027$414,482 - $414,482

Identifying the molecular determinants of thermoadaptation and parasitic growth of Histoplasma capsulatum

open
Jun 30, 2027$556,375 - $556,375

Mechanisms of control of allergic skin inflammation by T regulatory cells

open
Jun 30, 2030$716,281 - $716,281

Disrupting Apicoplast DNA Replication in Plasmodium: Identifying Key Proteases for Antimalarial Therapy

open
Jun 30, 2027$385,816 - $385,816

Form with function: Rapid phenotypic carbapenemase testing to improve detection of carbapenemase-producing organisms

open
Jun 30, 2029$3,055,197 - $3,055,197

INSPIRE: Innovative Strategies for Personalized Immunotherapies and Reservoir Eradication

open
May 31, 2030$2,948,452 - $2,948,452

Real-Time Detection of Staphylococcus aureus Transmission in Hospital Settings

open
Jun 30, 2029$3,210,845 - $3,210,845

ASB13 Control of EBV Life Cycle in B Cell and Epithelial Cell Cancers

open
Jun 30, 2030$691,788 - $691,788

Structural studies of the full-length nucleocapsid protein of SARS-CoV-2

open
Jun 30, 2027$489,500 - $489,500

NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS

open
Jul 20, 2027$3,626,906 - $3,626,906

Vaccine-mediated cross-alphavirus protection for a live attenuated FDA licensed chikungunya virus vaccine

open
Jun 30, 2029$3,248,576 - $3,248,576

Chromatin architecture regulating trained immunity in antiviral NK cells

open
Jun 30, 2029$3,519,992 - $3,519,992

A Point of Care Urine Test to Aid Diagnosis of Aspergillosis

open
Jun 30, 2028$999,316 - $999,316

Ethical, Legal, and Social Implications of the Human Virome

open
Jun 30, 2027$427,625 - $427,625

Lymphoid-specific high-efficiency beta-catenin protein degradation

open
Jun 30, 2029$3,131,408 - $3,131,408

Role of Tregs in the acquisition and maintenance of Tconv anergy in transplantation tolerance

open
Jun 30, 2030$766,265 - $766,265

Using Chemical Synthetic Lethality to Identify New Antimicrobial Targets in Gram-Negative Bacterial Pathogens

open
Jun 30, 2027$451,000 - $451,000

Repository of Monoclonal Antibodies (RoMA) against Hamster and Guinea Pig Proteins

open
Jun 30, 2030$835,137 - $835,137

Unravelling the role of aDb2 as a novel complement receptor in lung injury

open
Jun 30, 2027$489,500 - $489,500

Harnessing the soluble guanylate cyclase pathway to alleviate early life RSV bronchiolitis

open
Jun 30, 2027$364,484 - $364,484

Novel point-of-care liquid biopsy for early detection of sepsis-associated organ damage

open
Jun 30, 2027$473,937 - $473,937

EHD4 and its role on HIV-1 infection

open
Jun 30, 2027$238,972 - $238,972

Airway Innate Immune Responses to Coccidioides Infection

open
Jun 30, 2029$3,075,549 - $3,075,549

ϕSa3 prophage as a molecular regulatory switch of Staphylococcus aureus β-toxin production

open
Jun 30, 2030$560,178 - $560,178

Modeling and validating dynamic accessibility to healthcare with system science approach

open
Jun 30, 2027$137,064 - $137,064

Antimicrobial peptides and antibiotic diffusion in sputum

open
Jun 30, 2027$423,500 - $423,500

Deciphering Central Nervous System Autoimmunity in Down Syndrome

open
Jul 28, 2028$37,336 - $37,336

Targeting host nuclear receptors for the resolution of Staphylococcus aureus Skin Infections

open
Jun 30, 2027$437,250 - $437,250

Establishing Human 2D and 3D Testicular Models to Elucidate Monkeypox Virus Tropism and Pathogenic Mechanisms in the Testes

open
Jul 31, 2027$156,500 - $156,500

Investigating the regulatory impact of the small regulatory RNA BecO on essential virulence factors in Pseudomonas aeruginosa

open
Jul 31, 2028$75,520 - $75,520

Ehrlichia modulation of RNA splicing to influence KIRREL1-regulated Hippo signaling

open
Jul 31, 2030$520,128 - $520,128

SSLs immune manipulation in S aureus colonization, infection, and a potential therapy against pneumonia

open
Jul 31, 2030$392,409 - $392,409

Memory Regulatory T cells in Recurring Malaria

open
Jul 31, 2030$650,020 - $650,020

Defining Protective IgGs to Food Allergy

open
Jul 31, 2030$806,466 - $806,466

C. albicans cell wall stress responses and TOR signaling

open
Jul 31, 2027$489,500 - $489,500

What do Pex4 and Pex22 do in apicomplexan membrane transport?

open
Jul 31, 2027$426,250 - $426,250

Impacts of non-antibiotic medications on microbiome-mediated protection against intestinal pathogens

open
Jul 31, 2027$125,809 - $125,809

Safer, More Effective Mpox/Smallpox Vaccine

open
Jul 31, 2027$431,750 - $431,750

A whole-cell inactivated vaccine for improved protection against tuberculosis

open
Jul 31, 2027$269,874 - $269,874

Environmental acquisition of ST398 Staphylococcus aureus by patients with chronic respiratory disease

open
Jul 31, 2027$77,750 - $77,750

An exploratory study of a new pH-responsive, ionizable hybrid nanocarrier for enchancing drug accumulation in bacterial biofilms

open
Jul 31, 2027$158,500 - $158,500

Novel, bio-inspired chloramine to treat cutaneous fungal infections without resistance generation potential

open
Jul 31, 2026$299,435 - $299,435

CD27-mediated immune suppression by HSPCs, innate immune cells or non-hematopoietic cells

open
Jul 31, 2027$427,625 - $427,625

Transcriptional and functional identity of human T follicular helper cells across tissues

open
Jul 31, 2027$246,750 - $246,750

Development of targeted nuclear receptor ligands as medical radiation countermeasures

open
Jul 31, 2027$157,500 - $157,500

Unraveling the Structural Architecture and Molecular Mechanisms of HIV-1 Cell-to-Cell

open
Jul 31, 2027$231,000 - $231,000

Defining the role of enterococci in reshaping Clostridioides difficile infection

open
Jul 31, 2030$812,200 - $812,200

The oral environment in food allergy development (ONEIDA)

open
Jun 30, 2029$6,732,986 - $6,732,986

Structure and mechanism of the polar tube invasion apparatus from microsporidian parasites

open
Jul 31, 2030$709,891 - $709,891

The Extracellular Matrix as a Determinant of Filovirus Infectivity.

open
Jul 31, 2027$480,249 - $480,249

Multi-Ancestry Genome-wide Association Analysis and Polygenic Risk Score of Moderate-to-Severe Asthma

open
Jul 31, 2027$458,634 - $458,634

The impact of antinuclear antibodies on alloimmune responses to renal transplants

open
Jul 31, 2026$332,690 - $332,690

Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success

open
Apr 30, 2029$400,579 - $400,579

Rickettsial CspA proteins and host microRNAs in exosome formation and pathogenesis

open
Jul 31, 2027$440,000 - $440,000

Optimization of a novel antimicrobial for pulmonary delivery to fight respiratory infections

open
Jul 31, 2027$184,375 - $184,375

Molecular mechanisms of enterovirus D68 viral entry mediated by the MFSD6 receptor

open
Jul 31, 2029$3,045,291 - $3,045,291

Immune responses associated with severe disease in patients with primary dengue infection

open
Jul 31, 2029$29,279 - $29,279

Structural and mechanistic study of bat NLRP6 inflammasome in detecting RNA viruses

open
Jul 31, 2030$451,836 - $451,836

Single arm trial of menstrual cups among economically vulnerable women to reduce Bacterial vaginosis and STIs through reduced harmful sexual and menstrual practices

open
Jul 31, 2027$139,891 - $139,891

Adaptation of an in vitro generated human skin model for tick feeding to study Borrelia burgdorferi transmission and colonization

open
Jul 31, 2027$417,845 - $417,845

Specialized Mitochondrial DNA Polymerases in African Trypanosomes

open
Jul 31, 2027$412,581 - $412,581

Improving herpes simplex virus vaccination efficacy and neonatal infection outcomes

open
Jul 31, 2027$49,538 - $49,538

UTS-1401: A Novel Mitigator of Radiation Injury

open
Jul 31, 2027$431,750 - $431,750

Decoding the Molecular and Antigenic Interactions in Orthopox Virus Entry

open
Jul 31, 2027$466,125 - $466,125

Influence of DNA methylation changes on gene expression from the inactive X chromosome in B cells

open
Jul 31, 2028$49,538 - $49,538

Chlamydia trachomatis modulation of host inflammasome

open
Jul 31, 2027$145,745 - $145,745

Animal Models to Develop New Regimens for S. aureus Implant-Associated Infections

open
Jul 31, 2029$3,266,329 - $3,266,329

Characterizing Respiratory Syncytial Virus Burden and Prevention in the United States

open
Jul 31, 2030$189,276 - $189,276

Diagnosis of tuberculosis and monitoring of treatment via RNA liquid biopsy

open
Jul 31, 2030$743,651 - $743,651

Differential regulation of cell cycle entry and apoptosis in cytolytic lymphocytes informed by primary immunodeficiency

open
Jul 31, 2030$764,591 - $764,591

Engineered Microbes to Mitigate Intestinal Radiation Damage

open
Jul 31, 2027$160,125 - $160,125

Phylogenetics, causal inference, and model diagnostics for longitudinal studies of infectious disease transmission and control

open
Jul 31, 2030$537,861 - $537,861

Regulatory mechanisms for nuclear cGAS

open
Jul 31, 2030$382,500 - $382,500

Uncovering the Sensory Mechanisms of Blood Detection by Mosquitoes Using Innovative Genetic Approaches

open
Jul 31, 2030$458,849 - $458,849

Multivariate machine learning analysis of blood-based RNA expression profiles to distinguish relapsing-remitting and progressive forms of multiple sclerosis

open
Jul 31, 2027$979,138 - $979,138

Replication and Evolution of Primate Lentiviruses.

open
Jul 31, 2029$2,505,639 - $2,505,639

Development of a novel mucosal CTL-based HIV vaccine.

open
Jul 31, 2027$423,500 - $423,500

Impact of breastmilk on Campylobacter jejuni survival

open
Jul 31, 2030$534,418 - $534,418

Host cell reprogramming by human papillomavirus E7 proteins

open
Jul 31, 2029$2,938,414 - $2,938,414

Antibiotic treatment failure of Klebsiella pneumoniae liver abscesses

open
Jul 31, 2027$427,625 - $427,625

Oral N-Acetylglucosamine as Anti-Neuroinflammatory Add-on therapy for Multiple Sclerosis (NANA-MS)

open
Jul 31, 2026$263,892 - $263,892

Genomic- informed development of a cheap, portable assay to rapidly profile drug-resistant bacterial infections

open
Jul 31, 2030$198,630 - $198,630

Transcriptional regulation of essential tissues by pioneer factor FoxA in schistosome parasites

open
Jul 31, 2028$37,703 - $37,703

Multi Parametric Total-Body Imaging of Immune Activation in Post Acute Sequelae of SARS-CoV-2 (PASC)

open
Jul 31, 2029$808,672 - $808,672

Paired inhibition of falciparum merozoite invasion

open
Jul 31, 2027$426,938 - $426,938

Mechanistic Study of HIV Gag in sequestering the CARD8 inflammasome

open
Jul 31, 2026$650,934 - $650,934

A collaborative cross mouse model of Salmonella Typhi Chronic Carriage

open
Jul 31, 2027$402,985 - $402,985

RNAi-mediated silencing methods for Xenopsylla cheopis, a primary vector forplague transmission.

open
Jul 31, 2027$153,000 - $153,000

Culturomic and metagenomic methods optimization to detect multi-strain C. difficile colonization and infection

open
Jul 31, 2027$233,250 - $233,250

Human cellular models of TB and innate immunity

open
Jul 31, 2027$489,500 - $489,500

Modulating drug efflux transporter expression on the macrophage reservoir of HIV

open
Jul 31, 2027$77,000 - $77,000

Validation of Chlamydia virulence determinants by complementation

open
Jul 31, 2027$431,750 - $431,750

Determining the role of antibody epitope specificity in regulating Fc effector functions

open
Jul 31, 2027$128,461 - $128,461

Exploring Factor H recruitment by Treponema pallidum to avoid complement-mediated killing

open
Jul 31, 2027$448,150 - $448,150

Molecular Basis of Receptor Interactions for Venezuelan Equine Encephalitis

open
Jul 31, 2027$155,454 - $155,454

Elucidating the immune function of the RNA helicase DDX6

open
Jul 31, 2027$454,288 - $454,288

Protease sensor for rapid and sensitive detection of Borrelia infections

open
Jul 31, 2027$436,236 - $436,236

Characterizing a novel hypoxia cell-cycle checkpoint in Cryptococcus

open
Jul 31, 2027$423,236 - $423,236

Therapeutic vaccine platform to boost immune responses in Tuberculosis

open
Jul 31, 2027$599,471 - $599,471

Mechanism of evasion of cyclic oligonucleotide-based anti-phage signaling system

open
Jul 31, 2027$453,750 - $453,750

Engineering commensal bacteria and probiotics for lactate conversion and treatment of sepsis

open
Jul 31, 2028$75,520 - $75,520

Assessing Time-to-Treatment Variability in Antiretroviral Penetration by Multimodal Imaging

open
Jul 31, 2030$1,414,502 - $1,414,502

A wastewater approach to viral transmission, evolution, and ecology

open
Jul 30, 2030$568,909 - $568,909

Spatial approaches for optimizing TB active case finding: an investigation of activity spaces, mobility patterns, and local burden of disease in Nairobi, Kenya

open
Jul 31, 2030$30,316 - $30,316

The Role of SSR42 in Virulence Factor Regulation in S. aureus

open
Jul 31, 2030$470,953 - $470,953

Deep Learning-Driven Biodosimetry for High-Throughput Radiation Triage via Chromosomal Aberration Detection

open
Jul 31, 2027$157,400 - $157,400

Anti-retroviral drugs to block HTLV-1 transmission in vivo

open
Jul 31, 2027$189,057 - $189,057

Inter-membrane lipid signaling for preserving Gram-negative outer membrane integrity and antibiotic resistance

open
Jul 31, 2027$430,375 - $430,375

Elucidating mechanisms of carbon dioxide detection in insects

open
Jul 31, 2028$49,538 - $49,538

HIV Drug Resistance in the New Antiretroviral Therapy Era in Kenya

open
Jul 31, 2029$181,923 - $181,923

Emerging Cockroach-associated Biocontaminants in Low-income Households

open
Jul 31, 2027$418,000 - $418,000

Elucidating the Role of MRSA SasF in Skin Colonization and Disease

open
Jul 31, 2027$38,093 - $38,093

Probing NADase function of bacterial Toll/interleukin-1 receptor (TIR) proteins: Starting with a CURE (Course-based Undergraduate Research Experience)

open
Jul 31, 2029$149,620 - $149,620

Programming Offspring Immunity By In Utero Exposure to Maternal Helminth Infection

open
Jul 31, 2027$451,000 - $451,000

Phenotypically amplified assay for rapid, automated determination of beta-lactam susceptibility

open
Jul 31, 2029$1,795,199 - $1,795,199

Developing a tick-borne Rickettsia isolate library.

open
Jul 31, 2027$160,500 - $160,500

Ebola Virus Life Cycle Modeling In Vivo

open
Jul 31, 2027$441,100 - $441,100

Evaluating human T cells specific for Mycobacterium tuberculosis antigens that are processed and presented by infected macrophages

open
Jul 31, 2030$813,450 - $813,450

Self-Administrated Multiplex Radiation Indicator (SAMURAI) Kit for field triage biodosimetry

open
Jun 30, 2030$542,053 - $542,053

Role of ZNF proteins in the establishment and maintenance of HIV latency

open
Jul 31, 2026$453,750 - $453,750

Mechanistic Target of Rapamycin (MTOR) in human and murine cryptococcosis

open
Jul 31, 2027$160,640 - $160,640

Characterization of P. aeruginosa sRNAs that are highly expressed in human chronic infections

open
Jul 31, 2030$775,184 - $775,184

Leveraging the sensitivity of antigen-specific T cells to interrogate disease mechanisms and identify therapeutic targets for Long COVID

open
Jul 31, 2027$175,428 - $175,428

Expanding Safe Water Access to Improve Health Outcomes in Appalachia: The Rural Water Filtration and Health (RWELL) Trial

open
Jul 31, 2030$832,818 - $832,818

Exploring polyamine toxicity and resistance in epidemic bacterial skin pathogens

open
Jul 31, 2029$2,976,652 - $2,976,652

STAT4 regulation of Th17 pathogenicity

open
Jul 31, 2030$632,423 - $632,423

Single-cell spatial-temporal understanding of the role of macrophage subsets in maintenance of lesion biology and local Mycobacterium tuberculosis infection outcome

open
Jul 31, 2027$450,500 - $450,500

Retroelement-mediated cis-regulation of embryonic hematopoiesis

open
Jul 31, 2027$434,375 - $434,375

Multivalent mRNA HIV vaccine using Envelopes from recently circulating viruses.

open
Jul 31, 2028$208,875 - $208,875

Therapeutic potential of targeting glia as an inflammatory mediator source and bacterial reservoir

open
Jul 31, 2027$413,542 - $413,542

Impact of Spatial and Social Determinants on Invasive Fungal Infection Risk

open
Jul 31, 2030$197,640 - $197,640

Clostridioides difficile Zinc-binding PBPs as anti-sporulation targets

open
Jul 31, 2029$2,872,722 - $2,872,722

Exogenous fatty acid utilization by Staphylococcus aureus

open
Jul 31, 2030$677,325 - $677,325

BioPROTAC-Mediated Degradation of HIV-1 Rev

open
Jul 31, 2027$227,588 - $227,588

Enhancing durability of V3 glycan vaccine responses in rhesus macaques

open
Jul 31, 2030$1,285,304 - $1,285,304

Evaluation of PEG-BPEI as a potential mitigator against gastrointestinal acute radiation syndrome

open
Jul 31, 2027$149,008 - $149,008

HIV Viral Load Testing Using CRISPR Cascade Signal Amplification

open
Jul 31, 2030$647,533 - $647,533

Cell specific roles of CD153 and CD30 in regulation of immune responses

open
Jul 31, 2027$441,375 - $441,375

Advancing lymphatic filariasis elimination with parasite genomic epidemiology

open
Jul 31, 2030$777,360 - $777,360

Role of Tick Metalloprotease Inhibitors in the Transmission of Borrelia burgdorferi

open
Jul 31, 2027$423,106 - $423,106

Statistical Methods to Leverage Immunologic Biomarkers and Complex Molecular Testing Data for Respiratory Diseases Vaccines Development

open
Jul 31, 2030$448,573 - $448,573

Hemozoin and liver stage malaria vaccine efficacy

open
Jul 31, 2027$183,276 - $183,276

Discovering accumulation guidelines and applying them to develop new antibiotics for Gram-negative pathogens

open
Jul 31, 2030$1,144,714 - $1,144,714

Activation and Evasion of the Inflammasome by Noncytotoxic Staphylococcus aureus

open
Jul 31, 2030$188,916 - $188,916

Mechanisms of HIV accessory protein mediated control of NK cell function

open
Jul 31, 2030$848,839 - $848,839

HIV Molecular Epidemiology (ME) Dashboard: Mapping HIV to Identify Prevention Gaps in Florida

open
Jul 31, 2030$812,427 - $812,427

Deciphering interactions between human T cells and cardiomyocytes in immune checkpoint inhibitor-related myocarditis

open
Jul 31, 2030$197,640 - $197,640

Validation of miRAD assay as a biodosimetry tool for radiological/nuclear triage applications in pediatric and geriatric population

open
Jul 31, 2027$159,075 - $159,075

Investigating structural and biochemical factors guiding concanamycin A biosynthesis

open
Jun 30, 2028$43,588 - $43,588

Nutrient acquisition and cyclic nucleotide signaling in Treponema pallidum as underpinnings of stealth pathogenicity

open
Jul 31, 2027$457,875 - $457,875

TCR-dependent and epigenetic mechanisms guiding influenza-specific CD4+ T cell responses in the lung

open
Jul 31, 2029$3,078,308 - $3,078,308

Selective Targeting of the PD-1+ HIV/SIV reservoir with novel anti-PD-1 chimeric antigen receptor T cells

open
Jul 31, 2030$862,398 - $862,398

Long-term impact of persistent parainfluenza virus infection

open
Jul 31, 2030$596,115 - $596,115

New role of NP Exoribonuclease in Lassa virus infection

open
Jul 31, 2030$576,501 - $576,501

Mechanisms of CD4 T cell help to myeloid cells in tuberculosis

open
Jul 31, 2029$2,863,501 - $2,863,501

B-SMART - Broadly neutralizing antibodies for SaRNA Mediated Antiviral Response Therapy

open
Jul 31, 2027$599,989 - $599,989

Multidimensional and longitudinal immune profiling of sepsis in Uganda

open
Jul 31, 2029$153,972 - $153,972

Control of intracellular Shigella in human macrophages.

open
Jul 31, 2026$80,477 - $80,477

Structural characterization of the elongasome and divisome in mycobacteria

open
Jul 31, 2030$492,000 - $492,000

Simultaneous Targeting of Immunoglobulin G and M Using Endopeptidase for Humoral Rejection in Xenotransplantation

open
Jul 31, 2027$444,125 - $444,125

A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting

open
Jul 31, 2027$107,296 - $107,296

SCH: New Bayesian Causal Structural Discovery and Reinforcement Learning Methods for Mental health in HIV Care

open
Jul 31, 2029$289,436 - $289,436

Novel therapeutics to treat TB by stimulating bacterial cAMP production

open
Jul 31, 2030$746,602 - $746,602

Specific Coxsackievirus B3 Binding Interactions with Bacteria

open
Jul 31, 2027$43,113 - $43,113

Developing an Intervention to Promote Early Introduction of Peanut and Egg to Reduce Food Allergy Risk

open
Jul 31, 2029$195,696 - $195,696

The Clinical History of Rectal and Urethral STIs among MSM: characterizing microbiome host immune interactions for diagnostic and vaccine advances

open
Jul 31, 2028$138,853 - $138,853

Sickle cell disease severity prediction from the magnetic signature and hemoglobin content of blood cells

open
Jul 31, 2027$150,220 - $150,220

Defining a Role for Atypical B Cells in RV-Induced Exacerbations of Allergic Asthma

open
Jul 31, 2027$38,921 - $38,921

Development and optimization of a peptide inhibitor of influenza virus splicing for broad-spectrum antiviral therapy

open
Jul 31, 2029$3,170,096 - $3,170,096

Evaluating the Functional Impact of Genetic Diversity on Malaria Vaccine Candidates

open
Jul 31, 2027$104,466 - $104,466

UCLA Rapid, Rigorous, Relevant Implementation Science Hub: Leveraging Implementation Science to End the HIV Epidemic

open
Jul 31, 2030$721,721 - $721,721

Classical dendritic cells (cDC1) govern cardiac allograft tolerance

open
Jul 31, 2029$36,673 - $36,673

Turicibacter modifies intestinal infection severity by modulating intestinal metabolites

open
Jul 31, 2027$262,410 - $262,410

Mechanisms of nuclear egress in herpesviruses

open
Jul 31, 2029$3,268,792 - $3,268,792

Informing Drug Synergy: Investigating Mycobacterial Membrane Protein Structure and Function

open
Jul 31, 2029$3,262,539 - $3,262,539

Novel Antiviral Agents Targeting Zika and Dengue Virus

open
Jul 31, 2027$80,000 - $80,000

Deciphering Genetic Susceptibility of Pemphigus through Immunomics

open
Jul 31, 2030$778,934 - $778,934

Development of antimicrobials based on principles of induced proximity

open
Jul 31, 2027$481,250 - $481,250

Determining the role of PARP14 in restricting HSV-1 replication

open
Jul 31, 2027$411,499 - $411,499

Dietary sugar-regulated recombinant protein production in the gut

open
Jul 31, 2027$427,625 - $427,625

Role of RNA modification in innate immune cell development and function

open
Jul 31, 2030$659,663 - $659,663

PS03, a bifunctional RNA therapeutic to induce exhaustion in diabetogenic T cells

open
Jul 31, 2026$380,000 - $380,000

A Novel Model for Development of Countermeasures to Mitigate Radiation-induced Cardiotoxicity

open
Jul 31, 2027$158,500 - $158,500

Non-sputum-based biomarkers for the detection of tuberculosis

open
Jul 31, 2030$850,711 - $850,711

Characterization of an RNA binding protein required for influenza virus replication

open
Jul 31, 2027$42,815 - $42,815

Leveraging prenatal tolerance to improve AAV/bNAb therapy outcomes in infancy

open
Jun 30, 2030$1,257,182 - $1,257,182

A Novel Strategy to Identify Protective T cell Epitopes for HPV Therapeutic Vaccine

open
Jul 31, 2027$131,166 - $131,166

Chemical composition-viability relationship of bioaerosols through spatial distribution and size-controlled measurements

open
Jul 31, 2027$429,000 - $429,000

Curing chronic Toxoplasma infection with novel and potent protease inhibitors

open
Jul 31, 2030$603,601 - $603,601

Exploiting the bacteriophage arsenal to discover novel classes of anti-biofilm agents

open
Jul 31, 2027$427,625 - $427,625

Epigenetic mechanisms of intestinal stem cell fate conversion in response to severe radiation injury

open
Jul 31, 2027$158,716 - $158,716

Impact of bat hibernation on metabolism and immunity to infection

open
Jul 31, 2030$464,296 - $464,296

Spatiotemporal interrogation of interactions of pneumolysin, pulmonary epithelium, and PMNs that result in age-associated susceptibility to Streptococcus pneumoniae disease

open
Jul 31, 2027$450,630 - $450,630

Biomarkers to identify regional exposure to radiation

open
Jul 31, 2027$156,000 - $156,000

IND-enabling development for IN-005, an inhaled muco-trapping mAb therapy against Influenza A

open
Jul 31, 2028$1,013,003 - $1,013,003

Development of Broadly Protective Vaccines against New World Arenaviruses

open
Jul 31, 2030$720,588 - $720,588

T Cell Alloreactivity and Organ Transplant Risk Stratification Models Using High-Resolution HLA and Genomic Data

open
Jul 31, 2030$606,609 - $606,609

Role of GRAIL in B cell tolerance and B-cell mediated inflammation

open
Jul 31, 2029$2,630,572 - $2,630,572

Dual function for an effector immunity protein in Pseudomonas aeruginosa biofilm biogenesis

open
Jul 31, 2027$52,538 - $52,538

HBV-specific T cell immunity in HBV/HIV coinfection

open
Jul 31, 2028$136,858 - $136,858

Role of Ca2+ in B. anthracis exosporium assembly

open
Jul 31, 2027$148,500 - $148,500

Translating germline-targeting HIV Env SOSIP immunization of infants: targeting bnAbs in early life

open
Jun 30, 2030$4,630,686 - $4,630,686

Funder Overview

Total Opportunities1000
Grants1000
Contracts0

Track this funder

Sign up to manage your relationship, add notes, and get notified about new opportunities.

Start Free Trial

Get personalized grant matches

Start your free trial to save opportunities, get AI-powered match scores, and manage your applications in one place.

Start Free Trial